<SEC-DOCUMENT>0001021771-22-000033.txt : 20220628
<SEC-HEADER>0001021771-22-000033.hdr.sgml : 20220628
<ACCEPTANCE-DATETIME>20220628163125
ACCESSION NUMBER:		0001021771-22-000033
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220623
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220628
DATE AS OF CHANGE:		20220628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KINGSTONE COMPANIES, INC.
		CENTRAL INDEX KEY:			0000033992
		STANDARD INDUSTRIAL CLASSIFICATION:	FIRE, MARINE & CASUALTY INSURANCE [6331]
		IRS NUMBER:				362476480
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-01665
		FILM NUMBER:		221050544

	BUSINESS ADDRESS:	
		STREET 1:		15 JOYS LANE
		CITY:			KINGSTON
		STATE:			NY
		ZIP:			12401
		BUSINESS PHONE:		516 374-7600

	MAIL ADDRESS:	
		STREET 1:		15 JOYS LANE
		CITY:			KINGSTON
		STATE:			NY
		ZIP:			12401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCAP GROUP INC
		DATE OF NAME CHANGE:	20050210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCAP GROUP INC/
		DATE OF NAME CHANGE:	19990702

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTECH CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>8-K DATED JUNE 23, 2022 RE EMPLOYMENT AGREEMENT AMENDMENTS
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:kins="http://kingstonecompanies.com/20220623" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_ea5f61622aab41bc9d751ddb6405e31d" contextRef="c20220623to20220623" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_ffabec57efd1456ea346d958bc7c4f74" contextRef="c20220623to20220623">0000033992</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_80335468e4574b79a6a0466af4db3d82" contextRef="c20220623to20220623">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="kins-20220623.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220623to20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000033992</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-23</xbrli:startDate><xbrli:endDate>2022-06-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><br />
  </div>

  <div style="font-family: 'Times New Roman', Times, serif;">
    <div>
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="color: #000000;">
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-size: 12pt;">Washington, D.C. 20549</div>

      <div><br />
      </div>

      <div style="text-align: center;">
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_db48f16b68b54d42a1f03887607d11af" contextRef="c20220623to20220623">8-K</ix:nonNumeric></div>

      <div style="text-align: center;">
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div><br />
      </div>

      <div style="text-align: center; font-size: 10pt;">Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div><br />
      </div>

      <div style="text-align: center; font-size: 10pt;">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_999c62f185aa49b68d574ec8e5089f89" contextRef="c20220623to20220623" format="ixt:datemonthdayyearen">June 23, 2022</ix:nonNumeric></div>

      <div><br />
      </div>

      <div style="text-align: center;">
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-bottom: 12pt; margin-left: auto; margin-right: auto;" /></div>

      <div style="text-align: center; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_5b90b89a57b1436d952ef7054c38fbe1" contextRef="c20220623to20220623">KINGSTONE COMPANIES, INC.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-size: 10pt;">(Exact Name of Registrant as Specified in Its Charter)</div>

      <div style="text-align: center;">
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-top: 12pt; margin-left: auto; margin-right: auto;" /></div>

      <div><br />
      </div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_26bae341cdca4a438c9b02a9ed54a28f" contextRef="c20220623to20220623">000-01665</ix:nonNumeric></div>

      <div style="text-align: center; font-size: 10pt;">(Commission File Number)</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">


  <tr>

    <td style="width: 50%; vertical-align: top; ">
              <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt; font-weight: bold; "><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_b6b2559e76b241ada7a646a239e328a4" contextRef="c20220623to20220623" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 50%; vertical-align: top; ">
              <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt; font-weight: bold; "><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_f86e65dd5034486db320f46109a273a9" contextRef="c20220623to20220623">36-2476480</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; margin-left: 0.7pt; font-size: 10pt;">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_4bd4d2dbf4b049449409a5b757e5bdfb" contextRef="c20220623to20220623">15 Joys Lane</ix:nonNumeric></div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_ba4f8b66f6384fffbfc90426fc66a2b2" contextRef="c20220623to20220623">Kingston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_b0d0d337706e44d29931a6b9926acee1" contextRef="c20220623to20220623" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_a0d547783d454b4088cb2bdc7adf4238" contextRef="c20220623to20220623">12401</ix:nonNumeric></div>

      <div style="text-align: center; font-size: 10pt;">(Address of principal executive offices, including zip code)</div>

      <div><br />
      </div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_11ae8a074ab44becbcdec3ffae34397c" contextRef="c20220623to20220623">845</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_250f1bd0646a418abc280f17faf84045" contextRef="c20220623to20220623">802-7900</ix:nonNumeric></div>

      <div style="text-align: center; font-size: 10pt;">(Registrant&#8217;s telephone number, including area code)</div>

      <div><br />
      </div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">NOT APPLICABLE</div>

      <div style="text-align: center; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

      <div><br />
      </div>

      <div style="text-align: left; font-size: 10pt;"> Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </div>

      <div><br />
      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="DSPFListTable">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_bd3e91b0773043b19432f73b7a2142dd" contextRef="c20220623to20220623" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                </td>

  </tr>


</table>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="DSPFListTable">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_0f48012ea73f4187bab9216eba6f2965" contextRef="c20220623to20220623" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
                </td>

  </tr>


</table>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="DSPFListTable">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c33f4e11402c41f8969ed03cce205f80" contextRef="c20220623to20220623" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
                </td>

  </tr>


</table>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="DSPFListTable">


  <tr>

    <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_b48f5e5166d040618bb2d6099785213e" contextRef="c20220623to20220623" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div><br />
      </div>

      <div>Securities registered pursuant to Section 12(b) of the Act:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">


  <tr>

    <td style="width: 41%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid #000000;">
              <div style="font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 14%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid #000000;">
              <div style="font-weight: bold;">Trading</div>
              <div style="font-weight: bold;">Symbol(s)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 41%; vertical-align: bottom; border-bottom: 2px solid #000000;">
              <div style="font-size: 10pt; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 41%; vertical-align: top; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_123de43c2b62480d81686a6782dfefdb" contextRef="c20220623to20220623">Common Stock, $0.01 par value per share</ix:nonNumeric><br />
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br />
            </td>

    <td style="width: 14%; vertical-align: bottom; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_a099d0e9bc554633affed62cd2e4be35" contextRef="c20220623to20220623">KINS</ix:nonNumeric><br />
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br />
            </td>

    <td style="width: 41%; vertical-align: bottom; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_80335468e4574b79a6a0466af4db3d82">Nasdaq Capital Market</span><br />
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: left; font-size: 10pt;"> Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
        of 1934 (&#167;240.12b-2 of this chapter): </div>

      <div><br />
      </div>

      <div style="text-align: left; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_d81a3762e185404a93465e5d6403756a" contextRef="c20220623to20220623" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div><br />
      </div>

      <div style="text-align: left; font-size: 10pt;"> If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
        provided pursuant to Section 13(a) of the Exchange Act. &#9744; </div>

      <div>
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

      <div> <br />
      </div>

      <div> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div> <br />
      </div>

    </div>

  </div>

  <div>
    <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Item 5.02.&#160; <span style="font-family: 'Times New Roman',Times,serif;"><span style="text-decoration: underline;">Departure of Directors
          or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></span></div>

    <div style="text-align: justify; margin-bottom: 12pt;"><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</span><span style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">On June 27, 2022, Kingstone Companies, Inc. (the &#8220;Company&#8221;) and Barry B. Goldstein, the Company&#8217;s President, Chief Executive Officer and Executive
        Chairman of the Board, entered into a Third Amended and Restated Employment Agreement (the &#8220;Amended Goldstein Employment Agreement&#8221;).&#160; The Amended Goldstein Employment Agreement is effective as of January 1, 2023 and expires on December 31, 2024.&#160;
        The Amended Goldstein Employment Agreement extends the expiration date of the employment agreement currently in effect for Mr. Goldstein from December 31, 2022 to December 31, 2024.</span></div>

    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pursuant to the Amended Goldstein Employment Agreement, Mr. Goldstein is entitled to receive an annual base
      salary of $500,000 (equal to what he is receiving pursuant to his existing employment agreement) and an annual bonus equal to 3% of the Company&#8217;s consolidated income from operations before taxes, exclusive of the Company&#8217;s consolidated net investment
      income (loss), net unrealized gains (losses) on equity securities and net realized gains (losses) on investments (&#8220;Income from Operations&#8221;), up to a maximum of 1.25 times his base annual salary.&#160; This is in contrast with a bonus equal to 6% of Income
      from Operations (up to a maximum of 2.5 times his base annual salary) provided for in his existing employment agreement.&#160; Mr. Goldstein has agreed to forego any long-term compensation that may be payable to him pursuant to his existing employment
      agreement and advised the Company that he did not seek to receive any long-term compensation pursuant to the Amended Goldstein Employment Agreement.&#160; P<span style="font-family: 'Times New Roman',Times,serif;">ursuant to the Amended
        Goldstein Employment Agreement, in the event that Mr. Goldstein&#8217;s employment is terminated by the Company without cause or he resigns for good reason (each as defined in the Amended Goldstein Employment Agreement), Mr. Goldstein would be entitled
        to receive his base salary and the 3% bonus for the remainder of the term.&#160; Mr. Goldstein would be entitled, under certain circumstances, to a payment equal to 1.5 times his then annual salary and his accrued 3% bonus in the event of the
        termination of his employment following a change of control of the Company.&#160; Under his existing employment agreement, he would be entitled, under certain circumstances, to a payment equal to 3.82 times his then annual salary and his accrued 6%
        bonus in the event of the termination of his employment following a change of control of the Company.</span></div>

    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Concurrently with the
        execution of the Amended Goldstein Employment Agreement, the Company and Mr. Goldstein entered into an agreement pursuant to which the vesting date for an aggregate of 211,391 shares of restricted stock previously granted to Mr. Goldstein pursuant
        to the Company&#8217;s Amended and Restated 2014 Equity Participation Plan (the &#8220;Equity Participation Plan&#8221;) was extended from December 31, 2022 (the expiration date of his existing employment agreement) to December 29, 2023 (to the extent of 50%) and
        December 30, 2024 (the expiration date of the </span><span style="font-size: 10pt;">Amended Goldstein Employment Agreement) <span style="font-family: 'Times New Roman',Times,serif;">(to the extent of 50%), subject to acceleration under
          certain circumstances.</span></span></div>

    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">On June 27, 2022, the Company and Meryl S. Golden, the Company&#8217;s Chief Operating Officer, entered into a
      Second Amended and Restated Employment Agreement (the &#8220;Amended Golden Employment Agreement&#8221;). The Amended Golden Employment Agreement is effective as of January 1, 2023 and expires on December 31, 2024.&#160; The Amended Golden Employment Agreement
      extends the expiration date of the employment agreement currently in effect for Ms. Golden from December 31, 2022 to December 31, 2024.&#160; Pursuant to the Amended Golden Employment Agreement, Ms. Golden is entitled to receive an annual base salary of
      $500,000 (equal to what she is receiving pursuant to her existing employment agreement) and an annual bonus equal to 3% of the Company&#8217;s Income from Operations, up to a maximum of 1.25 times her base annual salary.&#160; P<span style="font-family: 'Times New Roman',Times,serif;">ursuant to the Amended Golden Employment Agreement, in the event that Ms. Golden&#8217;s employment is terminated by the Company without cause or she resigns for good reason (each as defined in the Amended Golden
        Employment Agreement), Ms. Golden would be entitled to receive her base salary and the 3% bonus for the remainder of the term.&#160; Ms. Golden would be entitled, under certain circumstances, to a payment equal to 1.5 times her then annual salary and
        her accrued 3% bonus in the event of the termination of her employment following a change of control of the Company.&#160; Pursuant to the Amended Golden Employment Agreement, Ms. Golden will be entitled to receive under certain circumstances a grant,
        under the terms of the Equity Participation Plan, during each of 2023 and 2024, of a number of shares of restricted stock determined by dividing $136,500 by the fair market value of the Company&#8217;s common stock on the date of grant.&#160; The 2023 grant
        will become vested with respect to one-half of the award on the first anniversary of the grant date and one-half on December 31, 2024.&#160; The 2024 grant will become vested on December 31, 2024.&#160; The above grant was provided for in Mr. Goldstein&#8217;s
        existing employment agreement but is not provided for in </span>the Amended Goldstein Employment Agreement.&#160; In the event that the Company is precluded from making a grant to Ms. Golden in either 2023 or 2024, she would instead be entitled to a
      cash bonus of $136,500 for such year.</div>

    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">On June 23, 2022, the Company&#8217;s Board of Directors adopted certain amendments to the Equity Participation
      Plan (the &#8220;Amended Equity Participation Plan&#8221;) relating to, among other things, the acceleration of vesting of restricted stock grants in the event of a change in control of the Company.</div>

    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The foregoing descriptions of the Amended Goldstein Employment Agreement, the Amended Golden Employment
      Agreement and the Amended Equity Participation Plan do not purport to be complete and are qualified in their entirety by reference to the full text of the Amended Goldstein Employment Agreement, the Amended Golden Employment Agreement and the Amended
      Equity Participation Plan filed as Exhibits 10.1, 10.2 and 10.3, respectively, to this Current Report on Form 8-K, which are incorporated by reference herein.</div>

    <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Item 9.01.&#160; <span style="font-family: 'Times New Roman',Times,serif;"><span style="text-decoration: underline;">Financial Statements
          and Exhibits.</span></span></div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 6.92%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">(d)</div>
          </td>

    <td style="width: 93.08%; vertical-align: top; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">Exhibits:</div>
          </td>

  </tr>

  <tr>

    <td style="width: 6.92%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 7.36%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">10.1</div>
          </td>

    <td style="width: 85.71%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">Third Amended and Restated Employment Agreement, dated as of June 27, 2022, by and between Kingstone Companies, Inc. and Barry B. Goldstein</div>
          </td>

  </tr>

  <tr>

    <td style="width: 6.92%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 7.36%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">10.2</div>
          </td>

    <td style="width: 85.71%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">Second Amended and Restated Employment Agreement, dated as of June 27, 2022, by and between Kingstone Companies, Inc. and Meryl S. Golden</div>
          </td>

  </tr>

  <tr>

    <td style="width: 6.92%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 7.36%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">10.3</div>
          </td>

    <td style="width: 85.71%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">Amended and Restated 2014 Equity Participation Plan of Kingstone Companies, Inc.</div>
          </td>

  </tr>


</table>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
      its behalf by the undersigned hereunto duly authorized.</div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">


  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 38%;" colspan="2"><strong>KINGSTONE COMPANIES, INC.<br />
              </strong></td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" style="width: 35%;">&#160;</td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: left;">Dated:&#160; June 28, 2022<br />
              </div>
            </td>

    <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: left;">By: </div>
            </td>

    <td valign="top" align="left" style="width: 35%; border-bottom: #000000 2px solid; white-space: nowrap;">/s/ Barry B. Goldstein<br />
            </td>

    <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="bottom" align="left" style="width: 35%; white-space: nowrap;">Barry B. Goldstein<br />
            </td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" style="width: 35%;">Chief Executive Officer<br />
            </td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>

  <tr>

    <td valign="top" style="width: 50%;">&#160;</td>

    <td valign="top" style="width: 3%;">&#160;</td>

    <td valign="top" style="width: 35%;">&#160;</td>

    <td valign="top" style="width: 12%;">&#160;</td>

  </tr>


</table>
    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>kins-20220623.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://kingstonecompanies.com/20220623" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:kins="http://kingstonecompanies.com/20220623" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="kins-20220623_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="kins-20220623_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://kingstonecompanies.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>3
<FILENAME>kins-20220623_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>4
<FILENAME>kins-20220623_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://kingstonecompanies.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="kins-20220623.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://kingstonecompanies.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10_1.htm
<DESCRIPTION>B. GOLDSTEIN THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">THIRD AMENDED AND RESTATED
        EMPLOYMENT AGREEMENT </font><font style="font-size: 10pt;">(the &#8220;Employment Agreement&#8221;), dated June 27, 2022 (the &#8220;Contract Date&#8221;), by and between <font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">KINGSTONE
          COMPANIES, INC</font>., a Delaware corporation (the &#8220;Company&#8221;), and <font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">BARRY B. GOLDSTEIN </font>(the &#8220;Employee&#8221;).</font></div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">RECITALS</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Company and the Employee entered into that certain employment agreement dated January 20, 2017 (the &#8220;Employment Agreement&#8221;), which set forth the terms and conditions upon which the Employee was employed by the Company
        and upon which the Company compensated the Employee for his services through December 31, 2018; and</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12.1pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, <font style="font-family: 'Times New Roman',Times,serif;">the Employment Agreement was amended and restated (the &#8220;Amended Employment Agreement&#8221;) effective January 1, 2019 to set forth the terms and conditions
          upon which the Employee was employed by the Company and upon which the Company compensated the Employee for his services through December 31, 2021; and</font></font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12.1pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS, </font><font style="font-size: 10pt;">effective as of July 19, 2019, the Employee was appointed as the President and Chief Executive Officer of the Company; and</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12.1pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Amended Employment Agreement was amended and restated (the &#8220;Second Amended Employment Agreement&#8221;) effective as of January 1, 2020 to set forth the terms and conditions upon which the Employee is employed by the
        Company and upon which the Company&#160; compensates the Employee for his services through December 31, 2022; and</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12.1pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS, </font><font style="font-size: 10pt;">the Company and the Employee mutually desire to amend and restate the Second Amended Employment Agreement effective as of January 1, 2023 (the &#8220;Effective Date&#8221;) to provide for the
        continued services and employment of the Employee by the Company from and after the Effective Date, upon the terms and conditions hereinafter set forth; and</font></div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, except as otherwise provided herein, all amounts earned, and other obligations, for periods prior to the Effective Date shall be controlled by the Second Amended Employment Agreement.</font></div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOW, THEREFORE</font><font style="font-size: 10pt;">, in consideration of the foregoing and the mutual covenants hereinafter set forth, the parties hereto hereby agree as follows:</font></div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
      </font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">1. &#160; &#160; &#160; &#160; &#160; <u>EMPLOYMENT; TERM</u><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab"> &#160;&#160;</font></div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">1.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Company will continue to employ the Employee in its business, and the Employee will continue to perform duties for the
        Company, as its President, Chief Executive Officer and Executive Chairman of the Board of Directors of the Company (the &#8220;Board&#8221;), and as the President of COSI Agency, Inc. (&#8220;COSI&#8221;), for a term continuing from and after the Effective Date and
        terminating on December 31, 2024 (the &#8220;Expiration Date&#8221;), subject to earlier termination as hereinafter provided (the employment period, as earlier terminated as provided for herein, being referred to as the &#8220;Term&#8221;).</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">1.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Upon the expiration of the Term or the termination of the Employee&#8217;s employment with the Company for any reason whatsoever,
        whether during or following the Term, he shall be deemed to have resigned all of his positions as an employee, officer and director of the Company and of each and every subsidiary thereof.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>DUTIES</u></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u> <br>
      </u></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">2.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall serve as the Company&#8217;s President, Chief Executive Officer and Executive Chairman of the
        Board, and as the President of COSI.&#160; As the President and Chief Executive Officer of the Company, the Employee shall have and perform executive, administrative, and managerial duties customary for such a position, and such further duties of an
        executive character as shall, from time to time, be delegated or assigned to him by the Board or the Executive Committee of the Board.&#160; As Executive Chairman of the Board, the Employee shall represent and promote the Company to the investment
        community and maintain relationships with existing shareholders, investment bankers and analysts and such further duties of an executive character as shall, from time to time, be delegated or assigned to him by the Board consistent with the
        Employee&#8217;s position.&#160; As President of COSI, the Employee shall seek to expand the relationships of COSI with other insurance carriers, national and online agencies, and other intermediaries.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>DEVOTION OF TIME</u></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u> <br>
      </u></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">3.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall expend substantially all of his working time for the Company, shall devote his efforts,
        energy and skill to the services of the Company and the promotion of its interests and shall not take part in activities detrimental to the best interests of the Company. Notwithstanding the foregoing, during the term of the Third Amended and
        Restated Employment Agreement between Kingstone Insurance Company (&#8220;KICO&#8221;) and the Employee, dated ___________, 2022 (the &#8220;KICO Employment Agreement&#8221;), the Employee shall be entitled to devote such time as is necessary to the fulfillment of his
        duties and responsibilities as KICO&#8217;s Chief Investment Officer and Chairman of the Board.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">3.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall be permitted to engage in the following activities: (a) charity, social or civic work, (b) tend to
        personal financial and legal affairs, (c) engage in any other business or business-related activity, and (d) subject to the prior written consent of the Company (following Board approval not to be unreasonably withheld), serve on the board of
        directors of, or advisor to, other business organizations (including up to two for-profit boards, in addition to the Company and its related entities), in each case (i.e., (a) through (d) above), provided that such activities do not interfere or
        conflict with his substantially full-time services to the Company.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>COMPENSATION</u></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u> <br>
      </u></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For all services to be rendered by the Employee during the Term, and in consideration of the Employee&#8217;s representations and
        covenants set forth in this Agreement, the Employee shall be entitled to receive from the Company compensation as set forth in Sections 4.2 and 4.3 below.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall be entitled to receive a salary at the rate of five hundred thousand dollars ($500,000) for each of the
        calendar years of the Term (the &#8220;Base Salary&#8221;); provided, however, the Base Salary shall be reduced on a dollar-for-dollar basis to the extent of the salary payable by KICO to the Employee pursuant to the KICO Employment Agreement for the same
        period.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Subject to the terms and conditions hereof, the Employee shall also be entitled to receive from the Company, for each calendar year during the Term, a bonus (the
        &#8220;Bonus&#8221;) equal to three percent (3%) of the Company&#8217;s Net Income (as hereinafter defined) for such calendar year, not to exceed one hundred twenty-five percent (125%) of the Base Salary (the &#8220;Bonus Payments&#8221;).</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, the term &#8220;Net Income&#8221; for any particular calendar period shall mean the Company&#8217;s consolidated income
        from operations before taxes for such period determined in accordance with generally accepted accounting principles consistently applied, as audited and reported upon by the independent auditors of the Company, except that the Company&#8217;s
        consolidated net investment income (loss), net unrealized gains (losses) on equity securities and net realized gains (losses) on investments shall be excluded.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, in the event that this Agreement shall terminate on a date other than December 31 of any calendar year
        and for such calendar year, pursuant to the terms of this Agreement, the Employee is entitled to receive a Bonus through the termination date (the &#8220;Termination Date&#8221;), then the Company&#8217;s Net Income for such calendar year shall be determined for the
        period from the first day of such calendar year (the &#8220;Termination Year&#8221;) until the Termination Date by multiplying the Company&#8217;s Net Income for the period from the first day of the Termination Year until the end of the calendar quarter in which the
        Termination Date falls (the &#8220;Termination Quarter&#8221;) by a fraction, the numerator of which shall be the number of days from the first day of the Termination Year until the Termination Date and the denominator of which shall be the number of days from
        the first day of the Termination Year until the end of the Termination Quarter. In the event the Termination Quarter shall be other than the last calendar quarter of the Termination Year, notwithstanding that the term &#8220;Net Income&#8221; shall have the
        meaning ascribed to it by paragraph (b) hereof (as adjusted by the provisions of this paragraph (c)), the application of such term to this paragraph (c) shall not be subject to any adjustment based upon an audit or report of the Company&#8217;s
        independent auditors with respect to the Termination Year but instead shall be calculated and paid as provided for in paragraph (d) hereof.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Bonus for any calendar year shall be payable in the following calendar year within thirty (30) days following the
        receipt by the Company of the report of its independent auditors with regard to the Company&#8217;s Net Income for such calendar year, calculated in accordance with paragraph (b) hereof and otherwise consistent with the consolidated financial statements
        of the Company for the calendar year (the &#8220;Audited Financial Statements&#8221;), as set forth in any Form 10-K filed by the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;); provided, however, that, in the event the Audited Financial
        Statements are not available by February 28 of any calendar year, an interim Bonus payment, if any, shall be made based upon the unaudited consolidated financial statements of the Company for such calendar year, as determined by the Company&#8217;s chief
        financial officer and approved by the Company&#8217;s Compensation Committee. Following receipt of the Audited Financial Statements, an appropriate adjustment will be made to the Bonus amount, and the Company will pay any underpayment, or the Employee
        will return any overpayment, within fifteen (15) days of receipt of the Audited Financial Statements. Notwithstanding the foregoing, with respect to any Termination Year in which the Termination Quarter is other than the last calendar quarter of
        the Termination Year, the Bonus shall be payable within thirty (30) days following the determination by the Company&#8217;s chief financial officer of the Company&#8217;s Net Income through the end of the Termination Quarter, if any, calculated in accordance
        with paragraph (c) hereof and otherwise consistent with the consolidated financial statements of the Company for the period ended with the end of the Termination Quarter, as set forth in any Form 10- Q filed by the Company with the SEC.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.4</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall not be eligible to participate in any employee incentive compensation plan other than as expressly
        provided in this Agreement.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.5</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee has agreed to forego any long-term compensation amount that may be payable pursuant to Section 4.4, 6.4, 11.5,
        11.6 or 11.7 of the Second Amended Employment Agreement and has advised the Company that he does not seek to receive any long-term compensation pursuant to this Agreement.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>REIMBURSEMENT OF EXPENSES</u></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u> <br>
      </u></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">5.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Subject to Section 5.3 hereof, the Company shall pay directly, or reimburse the Employee for, all reasonable and necessary
        expenses and disbursements incurred by the Employee for and on behalf of the Company in the performance of his duties during the Term.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">5.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall submit to the Company, not less than once in each calendar month, reports of such expenses and
        disbursements in a form normally used by the Company, and receipts with respect thereto, and the Company&#8217;s obligations under Section 5.1 hereof shall be subject to compliance therewith. The Company acknowledges that the Employee has complied with
        his obligations under this Section 5.2 through the day prior to the Contract Date.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">5.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall be entitled to receive a monthly automobile allowance of one thousand dollars ($1,000)
        for any and all expenses related to the Employee&#8217;s automobile (i.e., lease payments, insurance, gas, tolls, parking and the like). Except for reimbursement of directly related automobile expenses (i.e., parking and tolls) incurred by the Employee
        while fulfilling his duties and responsibilities to the Company, but which are outside of the Employee&#8217;s normal day to day usage of his automobile, the Employee will not be entitled to any additional or alternative reimbursement for any other
        automobile related expenses.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>DISABILITY; INSURANCE</u></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u> <br>
      </u></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If, during the Term, the Employee, in the opinion of a majority of all of the members of the Board (excluding the Employee
        if he is a member), as confirmed by competent medical evidence, shall become physically or mentally incapacitated to perform his duties for the Company hereunder (&#8220;Disabled&#8221;) for a continuous period, then for the first twelve (12) months of such
        period he shall receive his full salary (subject to the following sentence, the &#8220;Salary Continuation Period&#8221;). In no event, however, shall the Employee be entitled to receive any payments under this Section 6.1 beyond the expiration or termination
        date of this Agreement. Effective with the date of his resumption of full employment, the Employee shall be re-entitled to receive his full salary. If such illness or other incapacity shall endure for a continuous period of at least twelve (12)
        months or for at least two hundred fifty (250) business days during any eighteen (18) month period, the Company shall have the right, by written notice, to terminate the Employee&#8217;s employment hereunder as of a date (not less than thirty (30) days
        after the date of the sending of such notice) to be specified in such notice. The Employee agrees to submit himself for appropriate medical examination to a physician of the Company&#8217;s designation as necessary for purposes of this Section 6.1.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The obligations of the Company under this Article 6 may be satisfied, in whole or in part, by payments to the Employee under
        a disability insurance policy provided by the Company and/or KICO.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding the foregoing, in the event that, at the time of any apparent incapacity, the Company has in effect a
        disability policy with respect to the Employee (other than disability coverage through the New York State Insurance Fund), the Employee shall be considered Disabled for purposes of Section 6.1 only if he is considered disabled for purposes of the
        policy.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.4</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the termination of the Employee&#8217;s employment based upon him becoming Disabled, as severance, the Employee
        shall be entitled to receive the Bonus compensation to which he is entitled until the expiration of the Salary Continuation Period pursuant to Section 4.3 hereof (i.e., the Termination Date shall be considered the last day of the Salary
        Continuation Period). The amount to be paid to the Employee pursuant to this Section 6.4 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any other or further compensation, rights or benefits
        hereunder or otherwise, including pursuant to Article 11.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>RESTRICTIVE COVENANTS</u></div>
    <div><br>
    </div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The services of the Employee are unique and extraordinary and essential to the business of the Company, especially since the Employee shall have access to the Company&#8217;s
        customer lists, producer lists, trade secrets and other privileged and confidential information essential to the Company&#8217;s business. Therefore, the Employee agrees that, if the term of his employment hereunder shall expire or his employment shall
        at any time terminate, with Cause (as hereinafter defined) and with or without Good Reason (as hereinafter defined), the Employee will not at any time during the Restrictive Covenant Period (as hereinafter defined), without the prior written
        consent of the Company, directly or indirectly, whether individually or as a principal, officer, employee, partner, shareholder, member, manager, director, agent of, or consultant or independent contractor to, any person, corporation, limited
        liability company, partnership, limited partnership or other entity (collectively, &#8220;Person&#8221;):</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">within any state in which the Company has a license to operate on the date on which the Employee ceases to be employed by
        the Company (the &#8220;Cessation Date&#8221;) (the &#8220;Territory&#8221;), engage or participate in a business which, as of the Cessation Date, is competitive with the&#160; business in which the Company is then engaged (&#8220;Competitive Business&#8221;) (it being understood and
        agreed that, without limiting the generality of the foregoing, Heritage, Ocean Harbor, US Coastal, United Insurance Holdings, TypTap and HCI are currently engaged in a Competitive Business and &#8220;Competitive Business&#8221; includes the business of a
        Coastline Homeowner&#8217;s Insurance Provider (as defined below) and/or the provision of automobile insurance for the ridesharing industry), and shall not make any investments in any such Competitive Business, except that the foregoing shall not
        restrict the Employee from (A) acquiring up to one percent (1%) of the outstanding voting stock of any Competitive Business whose securities are listed on a stock exchange or Nasdaq or (B) engaging or participating in the business of a Person which
        is not a Coastline Homeowner&#8217;s Insurance Provider.&#160; For purposes hereof, the term &#8220;Coastline Homeowner&#8217;s Insurance Provider&#8221; means a Person which, directly or indirectly, derives at least twenty-five percent (25%) of its gross premiums written for
        personal property insurance from policies as to which the insured premises are located (I) within two (2) miles of the nearest coastline and/or (II) in areas, such as Long Island and Cape Cod, typically avoided by carriers that focus on
        preferred/standard business, such as State Farm Insurance, due to hurricane exposure;</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">cause or seek to persuade any director, officer, employee, customer, client, account, agent, producer, reinsurer or supplier
        of, or consultant or independent contractor to, the Company, or others with whom the Company has a business relationship (collectively, &#8220;Business Associates&#8221;), to discontinue or materially modify the status, employment or relationship of such
        Person with the Company, or to become employed in any activity similar to or competitive with the activities of the Company; provided, however, that nothing in this Section shall restrict the Employee&#8217;s ability to cause or seek to persuade his
        daughter, Amanda Rofsky, to alter her relationship with the Company;</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">cause or seek to persuade any prospective customer, client, account or other Business Associate of the Company (which at or
        about the Cessation Date was then actively being solicited by the Company) to determine not to enter into a business relationship with the Company or to materially modify its contemplated business relationship;</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iv)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">hire, retain or associate in a business relationship with, directly or indirectly, any director, officer or employee of the
        Company; or</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(v)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">solicit or cause or authorize to be solicited, or accept, for or on behalf of him or any third party, any business from, or
        the entering into of a business relationship with, (A) others who are, or were within one (l) year prior to the Cessation Date, a customer, client, account or other Business Associate of the Company, or (B) any prospective customer, client, account
        or other Business Associate of the Company which at or about the Cessation Date was then actively being solicited by the Company.</font></div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The foregoing restrictions set forth in this Section 7.1(a) shall apply likewise during the Term.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, the term &#8220;Restrictive Covenant Period&#8221; shall mean the eighteen (18) month period commencing with the
        Cessation Date; provided, however, that, in the event that the Employee&#8217;s employment is terminated by the Employee for Good Reason, the term &#8220;Restrictive Covenant Period&#8221; shall mean the shorter of (i) the twelve (12) month period commencing with
        the Cessation Date and (ii) the period commencing with the Cessation Date and ending on the Expiration Date.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees to disclose promptly in writing to the Board all ideas, processes, methods, devices, business concepts,
        inventions, improvements, discoveries, know-how and other creative achievements (hereinafter referred to collectively as &#8220;discoveries&#8221;), whether or not the same or any part thereof is capable of being patented, trademarked, copyrighted, or
        otherwise protected, which the Employee, while employed by the Company, conceives, makes, develops, acquires or reduces to practice, whether acting alone or with others and whether during or after usual working hours, and which are related to the
        Company&#8217;s business or interests, or are used by the Company, or arise out of or in connection with the duties performed by the Employee. The Employee hereby transfers and assigns to the Company all right, title and interest in and to such
        discoveries (whether conceived, made, developed, acquired or reduced to practice on or prior to the Effective Date or during his employment with the Company), including any and all domestic and foreign copyrights and patent and trademark rights
        therein and any renewals thereof. On request of the Company, the Employee will, without any additional compensation, from time to time during, and after the expiration or termination of, the Term, execute such further instruments (including,
        without limitation, applications for copyrights, patents, trademarks and assignments thereof) and do all such other acts and things as may be deemed necessary or desirable by the Company to protect and/or enforce its right in respect of such
        discoveries. All expenses of filing or prosecuting any patent, trademark or copyright application shall be borne by the Company, but the Employee shall cooperate, at the Company&#8217;s expense, in filing and/or prosecuting any such application.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee represents that he has been informed that it is the policy of the Company to maintain as secret all confidential information relating to the Company,
        including, without limitation, any and all knowledge or information with respect to secret or confidential methods, processes, plans, materials, customer, producer and reinsurer lists or data, or with respect to any other confidential or secret
        aspect of the Company&#8217;s activities, and further acknowledges that such confidential information is of great value to the Company. The Employee recognizes that, by reason of his employment with the Company, he has acquired and will acquire
        confidential information as aforesaid. The Employee confirms that it is reasonably necessary to protect the Company&#8217;s goodwill, and, accordingly, hereby agrees that he will not, directly or indirectly (except where authorized by the Board), at any
        time during the Term or thereafter divulge to any Person, or use, or cause or authorize any Person to use, any such confidential information.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees that he will not, at any time, remove from the Company&#8217;s premises any drawings, notebooks, software,
        data or other confidential information relating to the business and procedures heretofore or hereafter acquired, developed and/or used by the Company, except where necessary in the fulfillment of his duties hereunder.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notice Under Defend Trade Secrets Act: Notwithstanding the requirements contained in this Agreement, in accordance with the
        Defend Trade Secrets Act, Employee will not be held criminally or civilly liable under any federal or state trade secret law if Employee discloses a Trade Secret in confidence to federal, state or local government officials, to Employee&#8217;s attorney
        solely for the purpose of reporting or investigating a suspected violation of law, or in a sealed complaint or other document filed in a lawsuit or other proceeding. Further, if Employee files a lawsuit alleging retaliation by the Company for
        reporting a suspected violation of law, Employee may disclose the Trade Secret to his attorney and use the Trade Secret information in the court proceeding if Employee: (i) files the document containing the Trade Secret in a sealed court document;
        and (ii) does not disclose the Trade Secret, except pursuant to court order. However, if Executive engages in conduct otherwise prohibited by law, such as, but not limited to, accessing Trade Secrets unlawfully or by unauthorized means, no immunity
        shall apply and the Company reserves the right to pursue all available remedies.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees that, upon the expiration or termination of this Agreement or the termination of his employment with the
        Company for any reason whatsoever, he shall promptly deliver to the Company any and all drawings, notebooks, software, data and other documents and material, including all copies thereof, in his possession or under his control relating to any
        confidential information or discoveries, or which is otherwise the property of the Company.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, the term &#8220;confidential information&#8221; shall mean all information given to the Employee, directly or
        indirectly, by the Company and all other information relating to the Company otherwise acquired by the Employee during the course of his employment with the Company (whether on or prior to the Effective Date or hereafter), other than information
        which (i) was in the public domain at the time furnished to, or acquired by, the Employee, or (ii) thereafter enters the public domain other than through disclosure, directly or indirectly, by the Employee or others in violation of an agreement of
        confidentiality or nondisclosure.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(f)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">This Section 7.3 shall not be construed to unreasonably restrict the Employee&#8217;s ability to disclose confidential information
        in an arbitration proceeding or a court proceeding in connection with the assertion of, or defense against any claim of breach of this Agreement in accordance with Articles 12 and 14. In addition, nothing in this Agreement prohibits the Employee
        from reporting possible violations of federal or state law or regulation to any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of federal or state law or regulation.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.4</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes of this Article 7, the term &#8220;Company&#8221; shall mean and include the Company and any and all subsidiaries and
        affiliated entities of the Company in existence from time to time.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.5</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In connection with his agreement to the restrictions set forth in this Article 7, the Employee acknowledges the benefits
        accorded to him pursuant to the provisions of this Agreement, including, without limitation, the agreement on the part of the Company to employ the Employee during the Term (subject to the terms and conditions hereof). The Employee also
        acknowledges and agrees that the covenants set forth in this Article 7 are reasonable and necessary in order to protect and maintain the proprietary and other legitimate business interests of the Company and that the enforcement thereof would not
        prevent the Employee from earning a livelihood.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>VACATIONS; LEAVE</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The Employee shall be entitled to an aggregate of five (5) weeks&#8217; vacation time for each twelve (12) month period during the
      Term, the time and duration thereof to be determined by mutual agreement between the Employee and the Board. Any vacation time not used by the end of the Term shall be forfeited without compensation. In addition, the Employee shall not be entitled to
      carry over or use any vacation time that is unused as of the end of any twelve (12) month period during the Term. Further, the Employee shall be entitled to the number of sick, personal, family and other days off during each twelve (12) month period
      of the Term as set forth in KICO&#8217;s employee handbook. The Company acknowledges that the Employee has complied with his obligations under this Article 8 through the Contract Date.<br>
      <div><br>
      </div>
      9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>PARTICIPATION IN EMPLOYEE BENEFIT PLANS; STOCK AWARDS</u></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
    </div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">9.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall be accorded the right to participate in and receive benefits under and in accordance with the provisions
        of any pension, insurance, medical and dental insurance or reimbursement (with spousal coverage) or other plan or program of the Company or KICO, either in existence as of the Effective Date or thereafter adopted for the benefit generally of its
        executive employees. Additionally, in the event of termination of the Employee&#8217;s employment by the Company without Cause, or by the Employee for Good Reason, the Company or KICO shall continue to provide to the Employee health, dental, and vision
        insurance coverage at no cost to the Employee (with spousal coverage) until the Expiration Date or such time as the Employee becomes eligible for similar coverage through a successor employer, whichever is sooner (provided that the cost of such
        coverage shall be treated as taxable income to the Employee monthly to the extent necessary to enable the health plan to continue to satisfy applicable nondiscrimination requirements of Section 105(h) of the Internal Revenue Code of 1986, as
        amended (the &#8220;Code&#8221;), and the Patient Protection and Affordable Care Act (the &#8220;Affordable Care Act&#8221;).</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">9.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For each calendar year of the Term, the Employee will be eligible to participate in the Kingstone Companies, Inc. Amended
        and Restated 2014 Equity Participation Plan (the &#8220;Equity Plan&#8221;) on such basis as determined in the discretion of the Board or an authorized committee thereof in accordance with the terms of the Equity Plan.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">9.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Pursuant to a letter agreement of even date between the Company and the Employee, the parties are agreeing to change the
        vesting date for the unvested stock grants made pursuant to those certain Stock Grant Agreements, dated as of January 3, 2020, January 4, 2021 and January 3, 2022, between the Company and the Employee.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>SERVICE AS OFFICER AND DIRECTOR</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">During the Term, the Employee shall, if elected or appointed, serve as (a) an officer of the Company and/or any subsidiaries of the Company in
      existence or hereafter created or acquired and (b) a director of the Company and/or any such subsidiaries of the Company in existence or hereafter created or acquired, in each case without any additional compensation for such services. In the event
      the Company has in effect during the Term a director and officer liability insurance policy, the Company will include the Employee therein as a named insured.<br>
      <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>EARLIER TERMINATION</u></div>
    <div><br>
    </div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee&#8217;s employment hereunder (a) shall automatically terminate upon his death, (b) may terminate at any time during
        the Term at the option of the Company upon written notice to the Employee for Cause or without Cause, (c) may terminate at any time during the Term at the option of the Employee upon written notice to the Company for Good Reason or without Good
        Reason and (d) may terminate at the option of the Company in the event the Employee becomes Disabled, as provided for in Article 6.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">As used in this Agreement, &#8220;Cause&#8221; shall mean (a) the Employee&#8217;s commission of any act in the performance of his duties
        constituting common law fraud, a felony or other gross malfeasance of duty, (b) the Employee&#8217;s commission of any act involving moral turpitude which reasonably may have a material adverse effect on the Company and its subsidiaries taken as a whole
        (&#8220;Material Adverse Effect&#8221;), (c) any misrepresentation by the Employee (including, without limitation, a breach of any representation set forth in Article 13 hereof) which reasonably may have a Material Adverse Effect, (d) any breach of any
        material covenant on the Employee&#8217;s part herein set forth (which breach, if curable, is not cured by the Employee within thirty (30) days of the Employee&#8217;s receipt of written notice thereof from the Company), or (e) the Employee&#8217;s engagement in
        other intentional or grossly negligent misconduct which may reasonably have a Material Adverse Effect. The parties agree that the term &#8220;Material Adverse Effect&#8221; includes the loss or suspension of any license for the Company or KICO to operate or
        any disqualification or suspension for the Employee to serve as an officer or director thereof under applicable law.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">As used in this Agreement, &#8220;Good Reason&#8221; shall mean (a) any material breach of this Agreement on the Company&#8217;s part (which
        breach, if curable, is not cured by the Company within thirty (30) days of the Company&#8217;s receipt of written notice thereof from the Employee), (b) a material diminution in the Employee&#8217;s duties and responsibilities (other than following an event
        constituting Cause) in his capacity as the Company&#8217;s President, Chief Executive Officer and Executive Chairman of the Board, and as President of COSI Agency, Inc., (c) a material adverse change in the Employee&#8217;s current reporting structure (other
        than following an event constituting Cause), (d) a material decrease in the compensation payable to the Employee from the compensation payable pursuant to this Agreement, (e) the Employee&#8217;s termination under the KICO Employment Agreement by KICO
        other than for Cause, or (f) the relocation of the location of the Company&#8217;s principal offices at which the Employee is to provide his services to a location that is more than thirty (30) miles from Valley Stream, New York (it being understood and
        agreed, however, that the Employee shall be required to travel to Kingston, New York as often as is reasonably required for him to perform his duties as Chairman of the Board of KICO). Good Reason shall only exist if (i) notice is given within
        ninety (90) days of the initial event, (ii) such event is not cured within thirty (30) days of the giving of such notice, and (iii) Employee terminates employment within sixty (60) days of the end of the cure period.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.4</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the termination of the Employee&#8217;s employment by the Company for Cause or by the Employee without Good
        Reason, the Company shall have no further obligations to the Employee, and the Employee shall be entitled to no further compensation from the Company, except for any pro-rata amounts due to the Employee at such date of termination, as provided for
        in Section 4.2 hereof, and except, in the case of a termination of employment by the Employee without Good Reason, for any Bonus amount for the completed calendar year immediately preceding the date of termination, as provided in Section 4.3
        hereof. As an illustration of the foregoing, in the event of a termination of employment by the Employee without Good Reason on March 1, the Employee would be entitled to receive the amount payable to him pursuant to Section 4.2 hereof to March 1
        and the amount, if any, payable to him pursuant to Section 4.3 hereof for the immediately preceding calendar year ended December 31. In the event of the termination of the Employee&#8217;s employment by the Company for Cause or by the Employee without
        Good Reason, the amount to be paid to the Employee pursuant to this Section 11.4 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any other or further compensation, rights or benefits
        hereunder or otherwise.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.5</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the termination of the Employee&#8217;s employment by the Company without Cause or by the Employee for Good
        Reason, the Employee shall be entitled to receive (a) the compensation to which he would have been entitled until the expiration of the Term pursuant to Section 4.2 hereof and (b) the Bonus compensation to which he is entitled to receive through
        the expiration of the Term pursuant to Section 4.3 hereof.&#160; The compensation payable pursuant to (a) above shall be payable to the Employee in accordance with the Company&#8217;s standard payroll practices as if his employment had continued. The amount
        to be paid to the Employee pursuant to this Section 11.5 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any other or further compensation, rights or benefits hereunder or otherwise.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.6</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In order to protect the Employee against the possible consequences and uncertainties of a Change of Control of the Company
        and thereby induce the Employee to remain in the employ of the Company, the Company agrees that:</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If, during the Term or thereafter, the Employee&#8217;s employment is terminated by the Company other than for Cause or by the
        Employee for Good Reason within eighteen (18) months subsequent to a Change of Control that occurs during the Term, the Company shall pay to the Employee an amount in cash equal to the sum of (i) one and one-half (1.5) times the Base Salary (as
        reduced pursuant to Section 4.2) and (ii) the Bonus through the Termination Date, calculated pursuant to Section 4.3(c) (the &#8220;Change of Control Payment&#8221;). The Change of Control Payment shall be payable in one lump sum payment within ten (10) days
        following the date of termination of the Employee except for the Bonus through the Termination Date, which shall be payable within thirty (30) days following the determination by the Company&#8217;s chief financial officer of the Company&#8217;s Net Income
        through the end of the Termination Quarter, if any, and otherwise consistent with the consolidated financial statements of the Company for the period ended with the end of the Termination Quarter, as set forth in any Form 10-Q filed by the Company
        with the SEC. In addition, in such event, if the Employee is covered by the Company&#8217;s health, dental, or vision insurance, the Company shall continue to pay, on a monthly basis, for the Employee&#8217;s health insurance premiums, including spousal
        coverage, for the remainder of the Term, and thereafter the Employee and the Employee&#8217;s spouse shall continue to be provided, for the remainder of their lives, with the same access to the Company&#8217;s health, dental, and vision insurance to which the
        Employee was accorded during the Term, at COBRA premium rates, which will be paid for by the Employee or the Employee&#8217;s spouse (provided that the cost of such coverage attributable to Employer contributions shall be treated as taxable income to the
        Employee monthly to the extent necessary to enable the health plan to continue to satisfy applicable nondiscrimination requirements of Section 105(h) of the Code and the Affordable Care Act). The Change of Control Payment shall be in lieu of the
        amount payable to the Employee pursuant to Section 11.5 hereof; provided, however, that the Employee may elect to receive the amount payable pursuant to Section 11.5 hereof in lieu of the amount payable pursuant to this Section 11.6.&#160; In addition,
        in such event, following the Expiration Date, the Employee and the Employee&#8217;s spouse shall continue to be provided for life with the same access to the Company&#8217;s health, dental, and vision insurance to which the Employee was accorded during the
        Term, at COBRA premium rates which will be paid for by the Employee. The amount to be paid to the Employee pursuant to this Section 11.6 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any
        other or further compensation, rights or benefits hereunder or otherwise.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">As used in this Section 11.6, a &#8220;Change of Control&#8221; shall be deemed to have occurred if:</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">any &#8220;person&#8221; or &#8220;group of persons&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of
        1934, as amended (the &#8220;1934 Act&#8221;) (other than the Employee or any &#8220;group of persons&#8221; that includes the Employee), becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 promulgated under the 1934 Act), directly or indirectly, of securities of the
        Company representing more than thirty-three and one-third percent (33-1/3%) of the Company&#8217;s then outstanding securities having the right to vote on the election of directors (&#8220;Voting Securities&#8221;), except that there shall be excluded from the
        calculation any Voting Securities acquired from the Company with respect to which the Employee gave his approval as a member of the Board;</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">when individuals who, as of the date hereof, constitute the Board (the &#8220;Incumbent Board&#8221;) cease for any reason to constitute
        at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least a majority of
        the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an
        actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or</font></div>
    <div style="margin-bottom: 6pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the Company consummates (A) a reorganization, merger or consolidation of the Company, with respect to which in each case all
        or substantially all of the Persons who were the beneficial owners of the Voting Securities of the Company immediately prior to such reorganization, merger or consolidation do not, following such reorganization, merger or consolidation,
        beneficially own, directly and indirectly, more than 50% of the then combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of the corporation or other Person resulting from such
        reorganization, merger of consolidation, or (B) the sale or other disposition of all or substantially all of the assets of the Company.</font></div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Notwithstanding the foregoing, no transaction or event shall constitute a Change of Control hereunder unless such transaction
      or event also constitutes a change in ownership or effective control of the Company within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(v) or (vi)(A)(2).</div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.7</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the death of the Employee during the Term, as severance, the Employee&#8217;s estate (the &#8220;Estate&#8221;) shall be
        entitled to receive (a) the Base Salary to which the Employee is entitled until the date of death of the Employee pursuant to Section 4.2; and (b) the Bonus compensation to which the Employee is entitled through the date of death (i.e., the
        Termination Date shall be considered the date of death).&#160; The amount to be paid to the Estate pursuant to this Section 11.7 shall constitute the sole and exclusive remedy of the Estate and any beneficiaries thereof, and neither the Estate nor any
        beneficiaries thereof shall be entitled to any other or further compensation, rights or benefits hereunder or otherwise, including pursuant this to Article 11.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.8</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The termination or expiration of this Agreement shall not affect the continuing operation and effect of Article 7 hereof,
        which shall continue in full force and effect according to its terms. In addition, the termination or expiration of this Agreement will not result in a termination or waiver of any rights and remedies that the Company may have under this Agreement
        and applicable law.<br>
      </font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>INJUNCTIVE RELIEF; REMEDIES</u></div>
    <div><br>
    </div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">12.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee acknowledges and agrees that, in the event he shall violate or threaten to violate any of the restrictions of
        Article 3 or 7 hereof, the Company will be without an adequate remedy at law and will therefore be entitled to enforce such restrictions by temporary or permanent injunctive or mandatory relief in any court of competent jurisdiction without the
        necessity of proving monetary damages.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">12.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees further that the Company shall have the following additional rights and remedies:</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the right and remedy to require the Employee to account for and pay over to the Company all monies and other consideration
        derived or received by him as the result of any transactions determined by an arbitrator or a court of competent jurisdiction to be a breach of any of the provisions of Section 7.1, and the Employee hereby agrees to account for and pay over such
        monies and other consideration to the Company; and</font></div>
    <div style="margin-bottom: 6pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the right to recover attorneys&#8217; fees incurred in any action or proceeding in which it seeks to enforce its rights under
        Article 7 hereof and is successful on any grounds; provided, however, that, in the event the Employee is the prevailing party in any such action or proceeding, the Company will pay to the Employee all reasonable attorneys&#8217; fees and costs incurred
        by the Employee in defending such action or proceeding.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">12.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Each of the rights and remedies enumerated above shall be independent of the other, and shall be severally enforceable, and
        all of such rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or in equity.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">12.4</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The parties hereto intend to and hereby confer jurisdiction to enforce the covenants contained in Section 7.1 upon the
        courts of any jurisdiction within the geographical scope of such covenants (a &#8220;Jurisdiction&#8221;). In the event that the courts of any one or more of such Jurisdictions shall hold such covenants unenforceable by reason of the breadth of their scope or
        otherwise, it is the intention of the parties hereto that such determination not bar or in any way affect the Company&#8217;s right to the relief provided above in the courts of any other Jurisdiction, as to breaches of such covenants in such other
        respective Jurisdictions, the above covenants as they relate to each Jurisdiction being, for this purpose, severable into diverse and independent covenants.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 13.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NO RESTRICTIONS</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The Employee hereby represents that neither the execution of this Agreement nor his performance hereunder will (a) violate,
      conflict with or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under the terms, conditions or provisions of any contract, agreement or other
      instrument or obligation to which the Employee is a party, or by which he may be bound, or (b) violate any order, judgment, writ, injunction or decree applicable to the Employee. In the event of a breach hereof, in addition to the Company&#8217;s right to
      terminate this Agreement, the Employee shall indemnify the Company and hold it harmless from and against any and all claims, losses, liabilities, costs and expenses (including reasonable attorneys&#8217; fees) incurred or suffered in connection with or as
      a result of the Company&#8217;s entering into this Agreement or employing the Employee hereunder.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ARBITRATION</u></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
    </div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">14.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Except with regard to Section 12.1 hereof and any other matters that are not a proper subject of arbitration, all disputes
        between the parties hereto concerning the performance, breach, construction or interpretation of this Agreement or any portion thereof, or in any manner arising out of this Agreement or the performance thereof, shall be submitted to binding
        arbitration, in accordance with the rules of the American Arbitration Association. The arbitration proceeding shall take place at a mutually agreeable location in Nassau County, New York or such other location as agreed to by the parties.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">14.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The award rendered by the arbitrator shall be final, binding and conclusive, shall be specifically enforceable, and judgment
        may be entered upon it in accordance with applicable law in an appropriate court in the State of New York, with no right of appeal therefrom.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">14.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Each party shall pay its or his own expenses of arbitration, and the expenses of the arbitrator and the arbitration
        proceeding shall be equally shared; provided, however, that, if, in the opinion of the arbitrator (or a majority of the arbitrators if more than one), any claim or defense was unreasonable, the arbitrator(s) may assess, as part of their award, all
        or any part of the arbitration expenses of the other party (including reasonable attorneys&#8217; fees) and of the arbitrator(s) and the arbitration proceeding against the party raising such unreasonable claim or defense; provided, further, that, if the
        arbitration proceeding relates to the issue of Cause for termination of employment, (a) if, in the opinion of the arbitrator (or a majority of the arbitrators if more than one), Cause existed, the arbitrator(s) shall assess, as part of their award,
        all of the arbitration expenses of the Company (including reasonable attorneys&#8217; fees) and of the arbitrator(s) and the arbitration proceeding against the Employee or (b) if, in the opinion of the arbitrator (or a majority of the arbitrators if more
        than one), Cause did not exist, the arbitrator(s) shall assess, as part of their award, all of the arbitration expenses of the Employee (including reasonable attorneys&#8217; fees) and of the arbitrator(s) and the arbitration proceeding against the
        Company.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>CODE SECTIONS 409A, 280G AND 4999.</u></div>
    <div><br>
    </div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">15.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The intent of the parties is that payments and benefits under this Agreement comply with Section 409A of the Code (together
        with the regulations and guidance promulgated thereunder, &#8220;Code Section 409A&#8221;), and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. To the extent that any provision hereof is
        modified in order to comply with Code Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to the parties hereto of the applicable
        provision without violating the provisions of Code Section 409A. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on the Employee by Code Section 409A as a result of the Company&#8217;s
        compliance with the terms of this Agreement.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">15.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing
        for the payment of any amounts or benefits constituting deferred compensation under Code Section 409A upon or following a termination of employment unless such termination of employment is also a &#8220;separation from service&#8221; within the meaning of Code
        Section 409A and, for purposes of any such provision of this Agreement, references to a termination of employment or like terms shall mean &#8220;separation from service.&#8221; If the Employee is deemed on the date of termination to be a &#8220;specified employee&#8221;
        within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provision of any benefit that is considered deferred compensation under Code Section 409A payable on account of a &#8220;separation from service,&#8221;
        such payment or benefit shall be made or provided at the date which is the earlier of (i) the expiration of the six (6) month period measured from the date of such &#8220;separation from service&#8221; of the Employee, and (ii) the date of the Employee&#8217;s death
        (the &#8220;Delay Period&#8221;). Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section 15.2 (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be
        paid or reimbursed to the Employee in a lump sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified herein.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">15.3</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">All expenses or other reimbursements under this Agreement shall be made on or prior to the last day of the taxable year
        following the taxable year in which such expenses were incurred by the Employee (provided that if any such reimbursements constitute taxable income to the Employee, such reimbursements shall be paid no later than March 15th of the calendar year
        following the calendar year in which the expenses to be reimbursed were incurred), and no such reimbursement or expenses eligible for reimbursement in any taxable year shall in any way affect the expenses eligible for reimbursement in any other
        taxable year.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">15.4</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes of Code Section 409A, the Employee&#8217;s right to receive any installment payments pursuant to this Agreement shall
        be treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., &#8220;payment shall be made within sixty (60) days&#8221;), the actual
        date of payment within the specified period shall be within the sole discretion of the Company.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">15.5</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding any other provisions of this Agreement to the contrary, in the event that any payments or benefits received
        or to be received by the Employee in connection with the Employee&#8217;s employment with the Company (or termination thereof) would subject the Employee to the excise tax imposed under Section 280G or 4999 of the Code (the &#8220;Excise Tax&#8221;), and, if the
        net-after tax amount (taking into account all applicable taxes payable by the Employee, including any Excise Tax) that the Employee would receive with respect to such payments or benefits does not exceed the net-after tax amount the Employee would
        receive if the amount of such payment and benefits were reduced to the maximum amount which could otherwise be payable to the Employee without the imposition of the Excise Tax, then, to the extent necessary to eliminate the imposition of the Excise
        Tax, reduction shall occur in the following order unless the Employee elects in writing a different order to the extent permitted under Code Sections 409A, 280G and 4999: (i) severance payment based on multiple of Base Salary and/or Bonus; (ii)
        other cash payments; (iii) any pro-rated Bonus paid as severance; (iv) acceleration of vesting of stock options with an exercise price that exceeds the then fair market value of stock subject to the option, provided such options are not permitted
        to be valued under Treasury Regulations Section 1.280G-1 Q/A &#8211; 24(c); (v) any equity awards accelerated or otherwise valued at full value, provided such equity awards are not permitted to be valued under Treasury Regulations Section 1.280G-1 Q/A &#8211;
        24(c); (vi) acceleration of vesting of stock options with an exercise price that exceeds the then fair market value of stock subject to the option provided such options are permitted to be valued under Treasury Regulations Section 1.280G &#8211; 1 Q/A &#8211;
        24(c); (vii) acceleration of vesting of all other stock options and equity awards; and (viii) within any category, reductions shall be from the last due payment to the first.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ASSIGNMENT</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">This Agreement, as it relates to the employment of the Employee, is a personal contract and the rights and interests of the
      Employee hereunder may not be sold, transferred, assigned, pledged or hypothecated.<br>
      <div><br>
      </div>
      17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>NOTICES</u></div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Any notice required or permitted to be given pursuant to this Agreement shall be deemed to have been duly given when delivered
      by hand or sent by certified or registered mail, return receipt requested and postage prepaid, overnight mail or courier, e-mail, or fax as follows:</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">If to the Employee:</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">P.O. Box 450</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Hewlett, New York 11557</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">bgoldstein@kingstonecompanies.com</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Fax Number: (516) 374-4484</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">If to the Company:</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Chairman, Compensation Committee</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">William Yankus</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">wyankus@comcast.net</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">or at such other address as any party shall designate by notice to the other party given in accordance with this Article 17.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>GOVERNING LAW</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of New York
      applicable to agreements made and to be performed entirely in New York without regard to conflicts of laws principles.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>WAIVER OF BREACH; PARTIAL INVALIDITY</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The waiver by either party of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any
      subsequent breach. If any provision, or part thereof, of this Agreement shall be held to be invalid or unenforceable, such invalidity or unenforceability shall attach only to such provision and not in any way affect or render invalid or unenforceable
      any other provisions of this Agreement, and this Agreement shall be carried out as if such invalid or unenforceable provision, or part thereof, had been reformed, and any court of competent jurisdiction or arbitrators, as the case may be, are
      authorized to so reform such invalid or unenforceable provision, or part thereof, so that it would be valid, legal and enforceable to the fullest extent permitted by applicable law.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ENTIRE AGREEMENT; AMENDMENT</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and there are no
      representations, warranties or commitments except as set forth herein. This Agreement supersedes all prior agreements, understandings, negotiations and discussions, whether written or oral, of the parties hereto relating to the subject matter hereof,
      including the Second Amended Employment Agreement, with regard to the Employee&#8217;s employment with the Company effective as of January 1, 2023. This Agreement may be amended, and any provision hereof waived, only by a writing executed by the party
      sought to be charged. No amendment or waiver on the part of the Company shall be valid unless approved by its Board.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 21.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>COUNTERPARTS</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which taken
      together shall constitute one and the same instrument.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 22.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>FACSIMILE AND EMAIL SIGNATURES</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Signatures hereon which are transmitted via facsimile or email shall be deemed original signatures.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 23.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>EXPENSES</u></div>
    <div><br>
    </div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">23.1</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Company agrees to pay the reasonable fees and expenses of legal counsel incurred by the Employee in connection with the
        drafting and negotiation of this Agreement.</font></div>
    <div style="margin-bottom: 6pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">23.2</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In addition to the right to indemnification conferred in Article Thirteenth of the Restated Certificate of Incorporation of
        the Company, as amended (the &#8220;Certificate of Incorporation&#8221;), and Article VII, Section 7 of the By-Laws of the Company, as amended (the &#8220;By- Laws&#8221;), the Employee shall have the right to have his expenses (including reasonable attorneys&#8217; fees)
        incurred in defending any action or proceeding as to which the Employee is entitled to be indemnified in advance of its final disposition advanced and paid promptly as set forth below upon incurring such expenses; provided, however, that an
        advancement of expenses incurred by the Employee shall be made only upon delivery to the Company of an undertaking by the Employee to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is
        no further right to appeal that the Employee is not entitled to be indemnified for such expenses under the Certificate of Incorporation or the By-Laws. The Company shall make advance payments of such expenses (including reasonable attorneys&#8217; fees)
        incurred within thirty (30) days of the Employee&#8217;s presentation of an invoice for such expenses.</font></div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 24.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>CONSTRUCTION</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">All references in this Agreement to &#8220;includes&#8221; and &#8220;including&#8221; shall be construed to include the words &#8220;without limitation&#8221;.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 25.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>REPRESENTATION BY COUNSEL; INTERPRETATION</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The Employee acknowledges that he has been represented by counsel, or has been afforded the opportunity to be represented by
      counsel, in connection with this Agreement. Accordingly, any rule of law or any legal decision that would require the interpretation of any claimed ambiguities in this Agreement against the party that drafted it has no application and is expressly
      waived by the Employee. The provisions of this Agreement shall be interpreted in a reasonable manner to give effect to the intent of the parties hereto.</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> 26.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>HEADINGS</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The headings and captions under articles and sections of this Agreement are for convenience of reference only and do not in any
      way modify, interpret or construe the intent of the parties or affect any of the provisions of this Agreement.</div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">[Remainder of page intentionally left blank. Signature page follows.]</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the day and year above written.</div>
    <div style="text-align: left; margin-left: 216pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: left; margin-left: 216pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">KINGSTONE COMPANIES, INC.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 180pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">By:</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 180pt;">&#160; /s/<br>
      </font></div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 180pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Meryl S. Golden</div>
    <div style="text-align: left; text-indent: 216pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Chief Operating Officer</div>
    <div style="margin-bottom: 12pt; font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left;"><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 216pt;">&#160;</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 180pt;"> /s/</font><font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 180pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Barry B. Goldstein</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><u>Approved</u></font><font style="font-size: 10pt;">:</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>/s/</u>_______________________</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">William Yankus</div>
    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Chair, Compensation Committee</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex10_2.htm
<DESCRIPTION>M. GOLDEN SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECOND
          AMENDED AND RESTATED EMPLOYMENT AGREEMENT</font><font style="font-size: 10pt;">, dated June 27, 2022, by and between <font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">KINGSTONE COMPANIES, INC</font>., a
          Delaware corporation (the &#8220;Company&#8221;), and <font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">MERYL S. GOLDEN</font> (the &#8220;Employee&#8221; or the &#8220;Executive&#8221;).</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">RECITALS</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Company and the Employee entered into that certain Employment Agreement, dated August 27, 2019 (the &#8220;Employment Agreement&#8220;), which sets forth the terms and conditions upon which the Employee was employed by the
          Company and upon which the Company compensated the Employee for her services through December 31, 2021.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Employment Agreement was amended and restated (the &#8220;Amended Employment Agreement&#8221;) effective as of January 1, 2021 to set forth the terms and conditions upon which the Employee is employed by the Company and upon
          which the Company compensates the Employee for her services through December 31, 2022.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Company and the Employee desire to amend and restate the Amended Employment Agreement effective as of January 1, 2023 (the &#8220;Effective Date&#8221;) to provide for the continued services and employment of the Employee by
          the Company from and after the Effective Date, upon the terms and conditions hereinafter set forth.</font></div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, all amounts earned and other obligations for periods prior to the Effective Date shall be controlled by the Amended Employment Agreement.</font></div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOW,
          THEREFORE</font><font style="font-size: 10pt;">, in consideration of the foregoing and the mutual covenants hereinafter set forth, the parties hereto hereby agree as follows:</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: normal;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160;&#160;</font>1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>EMPLOYMENT; TERM</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">1.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Company will continue to employ the Employee in its business, and the Employee will continue to work for the Company
          therein, as its Chief Operating Officer for a term commencing as of the Effective Date and terminating on December 31, 2024 (the &#8220;Expiration Date&#8221;), subject to earlier termination as hereinafter provided (the employment period, as earlier
          terminated as provided for herein, being referred to as the &#8220;Term&#8221;).</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">1.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Upon the expiration of the Term or the termination of the Employee&#8217;s employment with the Company for any reason
          whatsoever, whether during or following the Term, she shall be deemed to have resigned all of her positions as an employee, officer and director of the Company and of each and every subsidiary thereof.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160;&#160;</font>2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u>DUTIES</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">2.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall serve as the Company&#8217;s Chief Operating Officer and shall have and perform executive,
          administrative, and managerial duties customary for such a position, and such further duties of an executive character as shall, from time to time, be delegated or assigned to her by the Board of Directors of the Company (the &#8220;Board&#8221;) or the
          Chief Executive Officer of the Company (the &#8220;CEO&#8221;) consistent with the Employee&#8217;s position.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160;&#160;</font><font style="font-weight: normal;">3.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>DEVOTION
            OF TIME</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">3.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall expend substantially all of her working time for the Company, shall devote her best
          efforts, energy and skill to the services of the Company and the promotion of its interests and shall not take part in activities detrimental to the best interests of the Company.&#160;&#160; Notwithstanding the foregoing, during the term of the Second
          Amended and Restated Employment Agreement between Kingstone Insurance Company (&#8220;KICO&#8221;) and the Employee of even date (the &#8220;KICO Employment Agreement&#8221;), the Employee shall be entitled to devote such time as is necessary to the fulfillment of her
          duties and responsibilities as President and Chief Operating Officer of KICO, it being understood and agreed that such permitted activity is subject to the reduction in Base Salary (as hereinafter defined) provided for in Section 4.2 hereof.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">3.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall be permitted to engage in the following activities: (a) charity, social or civic work, (b) tend to
          personal financial and legal affairs, and (c) subject to the prior written consent of the Company (following Board approval), serve on the Board of Directors of, or advisor to, other business organizations, in each case (i.e., (a) through (c)
          above), provided that such activities do not interfere or conflict with her full-time services to the Company.&#160;&#160;</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">4.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>COMPENSATION</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For all services to be rendered by the Employee during the Term, and in consideration of the Employee&#8217;s representations
          and covenants set forth in this Agreement, the Employee shall be entitled to receive from the Company compensation as set forth in Section 4.2 below.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall be entitled to receive a salary at the rate of five hundred thousand dollars
          ($500,000) per annum (the &#8220;Base Salary&#8221;); provided, however, the Base Salary shall be reduced on a dollar-for-dollar basis to the extent of the salary payable by KICO to the Employee pursuant to the KICO Employment Agreement.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;"> </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Subject to the terms and conditions hereof, the Employee shall also be entitled to receive from the Company, for each calendar year during the Term, a bonus (the
          &#8220;Bonus&#8221;) equal to three percent (3%) of the Company&#8217;s Net Income (as hereinafter defined) for such calendar year, not to exceed one hundred twenty-five percent (125%) of the Base Salary (the &#8220;Bonus Payments&#8221;).</font></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, the term &#8220;Net Income&#8221; for any particular calendar period shall mean the Company&#8217;s consolidated income from operations before
        taxes for such period determined in accordance with generally accepted accounting principles consistently applied, as audited and reported upon by the independent auditors of the Company, except that the Company&#8217;s consolidated net investment income
        (loss), net unrealized gains (losses) on equity securities and net realized gains (losses) on investments shall be excluded.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, in the event that this Agreement shall terminate on a date other than December 31 of any calendar year and for such calendar
        year, pursuant to the terms of this Agreement, the Employee is entitled to receive a Bonus through the termination date (the &#8220;Termination Date&#8221;), then the Company&#8217;s Net Income for such calendar year shall be determined for the period from the first
        day of such calendar year (the &#8220;Termination Year&#8221;) until the Termination Date by multiplying the Company&#8217;s Net Income for the period from the first day of the Termination Year until the end of the calendar quarter in which the Termination Date
        falls (the &#8220;Termination Quarter&#8221;) by a fraction, the numerator of which shall be the number of days from the first day of the Termination Year until the Termination Date and the denominator of which shall be the number of days from the first day of
        the Termination Year until the end of the Termination Quarter. In the event the Termination Quarter shall be other than the last calendar quarter of the Termination Year, notwithstanding that the term &#8220;Net Income&#8221; shall have the meaning ascribed to
        it by paragraph (b) hereof (as adjusted by the provisions of this paragraph (c)), the application of such term to this paragraph (c) shall not be subject to any adjustment based upon an audit or report of the Company&#8217;s independent auditors with
        respect to the Termination Year but instead shall be calculated and paid as provided for in paragraph (d) hereof.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160;&#160;&#160;</font>(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The
        Bonus for any calendar year shall be payable in the following calendar year within thirty (30) days following the receipt by the Company of the report of its independent auditors with regard to the Company&#8217;s Net Income for such calendar year,
        calculated in accordance with paragraph (b) hereof and otherwise consistent with the consolidated financial statements of the Company for the calendar year (the &#8220;Audited Financial Statements&#8221;), as set forth in any Form 10-K filed by the Company
        with the Securities and Exchange Commission (the &#8220;SEC&#8221;); provided, however, that, in the event the Audited Financial Statements are not available by February 28 of any calendar year, an interim Bonus payment, if any, shall be made based upon the
        unaudited consolidated financial statements of the Company for such calendar year, as determined by the Company&#8217;s chief financial officer and approved by the Company&#8217;s Compensation Committee. Following receipt of the Audited Financial Statements,
        an appropriate adjustment will be made to the Bonus amount, and the Company will pay any underpayment, or the Employee will return any overpayment, within fifteen (15) days of receipt of the Audited Financial Statements. Notwithstanding the
        foregoing, with respect to any Termination Year in which the Termination Quarter is other than the last calendar quarter of the Termination Year, the Bonus shall be payable within thirty (30) days following the determination by the Company&#8217;s chief
        financial officer of the Company&#8217;s Net Income through the end of the Termination Quarter, if any, calculated in accordance with paragraph (c) hereof and otherwise consistent with the consolidated financial statements of the Company for the period
        ended with the end of the Termination Quarter, as set forth in any Form 10-Q filed by the Company with the SEC.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.4</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall not be eligible to participate in any employee incentive compensation plan other than as expressly
        provided in this Agreement.</font></div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">5.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>REIMBURSEMENT
            OF EXPENSES</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">5.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Subject to Section 5.3 hereof, the Company shall pay directly, or reimburse the Employee for, all reasonable and necessary
          expenses and disbursements incurred by the Employee for and on behalf of the Company in the performance of her duties during the Term.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">5.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall periodically submit to the Company reports of such expenses and disbursements in a form and at a
          frequency normally used by the Company, and receipts with respect thereto, and the Company&#8217;s obligations under Section 5.1 hereof shall be subject to compliance therewith</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">5.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall be entitled to receive a monthly automobile allowance of one thousand dollars ($1,000)
          for any and all expenses related to the Employee&#8217;s automobile (i.e., lease payments, insurance, gas, tolls, parking and the like).&#160; Except for reimbursement of directly related automobile expenses (i.e., parking and tolls) incurred by the
          Employee while fulfilling her duties and responsibilities to the Company, but which are outside of the Employee&#8217;s normal day to day commuting usage of her automobile, the Employee will not be entitled to any additional or alternative
          reimbursement for any other automobile related expenses.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">6.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>DISABILITY;
            INSURANCE</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If, during the Term, the Employee, in the opinion of a majority of all of the members of the Board (excluding the Employee
          if she is a member), as confirmed by competent medical evidence, shall become physically or mentally incapacitated to perform her duties for the Company hereunder (&#8220;Disabled&#8221;) for a continuous period, then for the first three (3) months of such
          period she shall receive her full salary (subject to the following sentence, the &#8220;Salary Continuation Period&#8221;).&#160; In no event, however, shall the Employee be entitled to receive any payments under this Section 6.1 beyond the expiration or
          termination date of this Agreement.&#160; Effective with the date of her resumption of full employment, the Employee shall be re-entitled to receive her full salary.&#160; If such illness or other incapacity shall endure for a continuous period of at least
          three (3) months or for at least sixty (60) business days during any six (6) month period, the Company shall have the right, by written notice, to terminate the Employee&#8217;s employment hereunder as of a date (not less than thirty (30) days after
          the date of the sending of such notice) to be specified in such notice.&#160; The Employee agrees to submit herself for appropriate medical examination to a physician of the Company&#8217;s designation as necessary for purposes of this Section 6.1.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The obligations of the Company under this Article 6 may be satisfied, in whole or in part, by payments to the Employee
          under a disability insurance policy provided by the Company and/or KICO.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding the foregoing, in the event that, at the time of any apparent incapacity, the Company has in effect a
          disability policy with respect to the Employee (other than disability coverage through the New York State Insurance Fund), the Employee shall be considered Disabled for purposes of Section 6.1 only if she is considered disabled for purposes of
          the policy.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.4.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the termination of the Employee&#8217;s employment based upon her becoming Disabled, as severance, the Employee
          shall be entitled to receive the Bonus compensation to which she is entitled until the expiration of the Salary Continuation Period pursuant to Section 4.3 hereof (i.e., the Termination Date shall be considered the last day of the Salary
          Continuation Period). The amount to be paid to the Employee pursuant to this Section 6.4 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any other or further compensation, rights or
          benefits hereunder or otherwise, including pursuant to Article 11.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">7.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>RESTRICTIVE
            COVENANTS</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The services of the Employee are unique and extraordinary and essential to the business of the Company, especially since the Employee shall have access to the
          Company&#8217;s customer lists, producer lists, trade secrets and other privileged and confidential information essential to the Company&#8217;s business.&#160; Therefore, the Employee agrees that, if her employment shall at any time terminate during the Term for
          any reason whatsoever, with or without Cause (as hereinafter defined) and with or without Good Reason (as hereinafter defined), the Employee will not at any time during the Restrictive Covenant Period (as hereinafter defined), without the prior
          written consent of the Company, directly or indirectly, whether individually or as a principal, officer, employee, partner, shareholder, member, manager, director, agent of, or consultant or independent contractor to, any person, corporation,
          limited liability company, partnership, limited partnership or other entity (collectively, &#8220;Person&#8221;):</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">within any state in which the Company has a license to operate on the date on which the Employee ceases to be employed by
          the Company (the &#8220;Cessation Date&#8221;) (the &#8220;Territory&#8221;), engage or participate in a business which, as of the Cessation Date, is competitive with the business in which the Company is then engaged (&#8220;Competitive Business&#8221;) (it being understood and
          agreed that, without limiting the generality of the foregoing, Heritage, Ocean Harbor, US Coastal, United Insurance Holdings, TypTap and HCI are currently engaged in a Competitive Business and &#8220;Competitive Business&#8221; includes the business of a
          Coastline Homeowner&#8217;s Insurance Provider (as defined below) and/or the provision of automobile insurance for the ridesharing industry), and shall not make any investments in any such Competitive Business, except that the foregoing shall not
          restrict the Employee from (A) acquiring up to one percent (1%) of the outstanding voting stock of any Competitive Business whose securities are listed on a stock exchange, including Nasdaq or (B) engaging or participating in the business of a
          Person which is not a Coastline Homeowner&#8217;s Insurance Provider.&#160; For purposes hereof, the term &#8220;Coastline Homeowner&#8217;s Insurance Provider&#8221; means a Person which, directly or indirectly, derives at least twenty-five percent (25%) of its gross
          premiums written for personal property insurance from policies as to which the insured premises are located (I) within two (2) miles of the nearest coastline and/or (II) in areas, such as Long Island and Cape Cod, typically avoided by carriers
          that focus on preferred/standard business, such as State Farm Insurance, due to hurricane exposure;</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">cause or seek to persuade any director, officer, employee, customer, client, account, agent, producer, reinsurer or
          supplier of, or consultant or independent contractor to, the Company, or others with whom the Company has a business relationship (collectively, &#8220;Business Associates&#8221;), to discontinue or materially modify the status, employment or relationship of
          such Person with the Company;</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">cause or seek to persuade any prospective customer, client, account or other Business Associate of the Company (which at
          or about the Cessation Date was then actively being solicited by the Company) to determine not to enter into a business relationship with the Company or to materially modify its contemplated business relationship; or</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iv)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">hire, retain or associate in a business relationship with, directly or indirectly, any director, officer or employee of
          the Company.</font></div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The foregoing restrictions set forth in this Section 7.1(a) shall apply likewise during the Term.</div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, the term &#8220;Restrictive Covenant Period&#8221; shall mean the twelve (12) month period commencing with the
          Cessation Date.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees to timely disclose to the Board and the CEO all material ideas, processes, methods, devices, business
          concepts, inventions, improvements, discoveries, know-how and other creative achievements, whether or not the same or any part thereof is capable of being patented, trademarked, copyrighted, or otherwise protected, which the Employee, while
          employed by the Company, conceives, makes, develops, acquires or reduces to practice, whether acting alone or with others and whether during or after usual working hours, and which are related to the Company&#8217;s business or interests, or are used
          or usable by the Company, or arise out of or in connection with the duties performed by the Employee (hereinafter referred to collectively as &#8220;Discoveries&#8221;).&#160; The Employee hereby transfers and assigns to the Company all right, title and interest
          in and to such Discoveries, including any and all domestic and foreign copyrights and patent and trademark rights therein and any renewals thereof.&#160; On request of the Company, the Employee will, without any additional compensation, from time to
          time during, and after the expiration or termination of, the Term, execute such further instruments (including, without limitation, applications for copyrights, patents, trademarks and assignments thereof) and do all such other acts and things as
          may be deemed necessary or desirable by the Company to protect and/or enforce its right in respect of such Discoveries.&#160; All expenses of filing or prosecuting any patent, trademark or copyright application shall be borne by the Company, but the
          Employee shall cooperate, at the Company&#8217;s expense, in filing and/or prosecuting any such application.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee represents that she has been informed that it is the policy of the Company to maintain as confidential all confidential and/or proprietary information
          relating to the Company, including, without limitation, any and all knowledge or information with respect to confidential methods, processes, plans, materials, customer, producer and reinsurer lists or data, or with respect to any other
          confidential or secret aspect of the Company&#8217;s activities, and further acknowledges that such confidential information is of great value to the Company.&#160; The Employee recognizes that, by reason of her employment with the Company, she has acquired
          and will acquire confidential information as aforesaid.&#160; The Employee confirms that it is reasonably necessary to protect the Company&#8217;s goodwill, and, accordingly, hereby agrees that she will not, directly or indirectly (except where authorized
          by the Board), at any time during the Term or thereafter divulge to any Person, or use, or cause or authorize any Person to use, any such confidential information.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees that she will not, at any time, remove from the Company&#8217;s premises any drawings, notebooks, software,
          data or other confidential information relating to the business and procedures heretofore or hereafter acquired, developed and/or used by the Company, except where necessary in the fulfillment of her duties hereunder.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees that, upon the expiration or termination of this Agreement or the termination of her employment with
          the Company for any reason whatsoever, she shall promptly deliver to the Company any and all drawings, notebooks, software, data and other documents and material, including all copies thereof, in her possession or under her control relating to
          any confidential information or discoveries, or which is otherwise the property of the Company.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, the term &#8220;confidential information&#8221; shall mean all information given to the Employee, directly or
          indirectly, by the Company and all other information relating to the Company otherwise acquired by the Employee during the course of her employment with the Company (whether on or prior to the Effective Date or hereafter), other than information
          which (i) was in the public domain at the time furnished to, or acquired by, the Employee, or (ii) thereafter enters the public domain other than through disclosure, directly or indirectly, by the Employee or others in violation of an agreement
          of confidentiality or nondisclosure.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.4.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes of this Article 7, the term &#8220;Company&#8221; shall mean and include the Company and any and all subsidiaries and
          affiliated entities of the Company in existence from time to time.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.5.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In connection with her agreement to the restrictions set forth in this Article 7, the Employee acknowledges the benefits
          accorded to her pursuant to the provisions of this Agreement, including, without limitation, the agreement on the part of the Company to employ the Employee during the Term (subject to the terms and conditions hereof). The Employee also
          acknowledges and agrees that the covenants set forth in this Article 7 are reasonable and necessary in order to protect and maintain the proprietary and other legitimate business interests of the Company and that the enforcement thereof would not
          prevent the Employee from earning a livelihood.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.6.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding any other provision of this Article 7 to the contrary, the Executive may disclose confidential or
          proprietary information of the Company and its subsidiaries as follows:&#160; (a) disclosures to directors, officers, key employees, independent accountants and counsel of the Company and its subsidiaries as may be necessary or appropriate in the
          performance of the Executive&#8217;s duties hereunder, (b) disclosures that do not have a material adverse effect on the business or operations of the Company and its subsidiaries taken as a whole, (c) disclosures that the Executive is required to make
          by law or by any court, arbitrator or administrative or legislative body (including any committee thereof) with apparent jurisdiction to order the Executive to disclose or make accessible any information, (d) disclosures with respect to any other
          litigation, arbitration or mediation involving this Agreement, and (e) disclosures of any such confidential or proprietary information that is, at the time of such disclosure, generally known to and available for use by the public and not by the
          Executive&#8217;s wrongful act or omission.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.7.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If Executive believes that she may be required to disclose any such confidential or proprietary information pursuant to
          applicable law, court order or subpoena, she shall immediately notify the Company in writing by overnight delivery, directed to the CEO, of any such perceived requirement so that the Company may seek an appropriate protective order or other
          appropriate remedy or waive compliance with this confidentiality requirement.&#160; Executive shall also reasonably cooperate with the Company to obtain such a protective order or other remedy.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.8.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding any other provision of this Article 7 to the contrary, the Executive upon leaving the employ of the
          Company shall be entitled to retain (i) papers and other materials of a personal nature, including but not limited to, photographs, correspondence, personal diaries, personal contact lists, calendars and personal files, except to the extent
          business-related information is set forth therein, (ii) information showing her compensation or relating to her reimbursement of expenses, (iii) information that she reasonably believes may be needed for tax purposes, and (iv) copies of plans,
          programs and agreements relating to her employment, or termination thereof, with the Company.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.9.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">This Agreement does not prohibit Executive from making any disclosure required by law, communicating with, making a report
          to, or otherwise participating in any investigation or proceeding that may be conducted by the Company&#8217;s designated legal, compliance or human resources personnel, the Securities and Exchange Commission (&#8220;SEC&#8221;) and/or its Office of the
          Whistleblower, the Equal Employment Opportunity Commission (&#8220;EEOC&#8221;), the Occupational Safety and Health Administration (&#8220;OSHA&#8221;), the National Labor Relations Board (&#8220;NLRB&#8221;), or other federal, state or local government agencies or entities.&#160;
          Executive is not prohibited from disclosing this Agreement or its contents, or from providing documents or other information, to the SEC and/or the Office of the Whistleblower, EEOC, OSHA, NLRB or any other such federal, state or local
          governmental entity.&#160; Executive does not need to provide notice to or obtain the prior authorization of Company&#8217;s CEO or General Counsel to make any such report or disclosure and Executive is not required to notify the Company that Executive has
          made such reports or disclosures.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.10.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif;"><u>Notice Under Defend Trade Secrets Act</u></font>:
          Notwithstanding the requirements contained in this Agreement, in accordance with the Defend Trade Secrets Act, Executive will not be held criminally or civilly liable under any federal or state trade secret law if Executive discloses a Trade
          Secret in confidence to federal, state or local government officials, to Executive&#8217;s attorney solely for the purpose of reporting or investigating a suspected violation of law, or in a sealed complaint or other document filed in a lawsuit or
          other proceeding.&#160; Further, if Executive files a lawsuit alleging retaliation by the Company for reporting a suspected violation of law, Executive may disclose the Trade Secret to her attorney and use the Trade Secret information in the court
          proceeding if Executive:&#160; (i) files the document containing the Trade Secret in a sealed court document; and (ii) does not disclose the Trade Secret, except pursuant to court order.&#160; However, if Executive engages in conduct otherwise prohibited
          by law, such as, but not limited to, accessing Trade Secrets unlawfully or by unauthorized means, no immunity shall apply and the Company reserves the right to pursue all available remedies.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.11.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding anything to the contrary in this Agreement, Executive has the right to:</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Report, respond to or cooperate with an investigation into possible violations of state or federal laws or regulations
          involving a governmental agency or entity including the Congress, the Department of Justice, the SEC and/or its Office of the Whistleblower (www.sec.gov/whistleblower); Office of the Whistleblower Hotline (202) 551-4790, the EEOC, the OSHA, the
          NLRB, and any other such federal, state or local agency.&#160; This includes reporting violations of the federal securities laws or regulations;</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Make disclosures that are protected by federal, state or local whistleblower laws;</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Cooperate in an investigation, respond to an inquiry, or provide testimony before the SEC or any other federal, state or
          local regulatory or law enforcement authority; and</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Make reports or disclosures to law enforcement or regulatory authorities without authorization from the Company, without
          notifying the Company that a report or disclosure will be or was made, and without revealing the substance of the report or disclosure to the Company.</font></div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Executive will not be retaliated against for reporting to the Company or to any governmental agency or
        entity, including the SEC, information that Executive reasonably believes relates to a possible violation of securities laws or for reporting misconduct. Retaliation under such circumstances is prohibited by law.</div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.12.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">This Agreement does not prevent, interfere with or limit Executive&#8217;s ability to file a charge or complaint with, report
          conduct to, provide information to or participate in any investigation or proceeding conducted by the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administrative, the Securities
          and Exchange Commission or any other federal, state or local government agency or commission.&#160; Executive agrees that, if such a charge or complaint is made, or investigation or proceeding is initiated against the Company, Executive will not
          accept, be entitled to, receive, or recover any monetary damages or any other form of relief or remedy to the fullest extent permitted by law EXCEPT THAT THIS AGREEMENT DOES NOT WAIVE OR LIMIT EXECUTIVE&#8217;S RIGHT TO RECEIVE A MONETARY AWARD FOR
          INFORMATION PROVIDED TO THE SEC AS AN SEC WHISTLEBLOWER OR TO RECEIVE A MONETARY AWARD FROM ANY OTHER FEDERAL OR STATE AGENCY PURSUANT TO A SIMILAR WHISTLEBLOWER PROGRAM.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">8.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>VACATIONS;
            LEAVE</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160;&#160;&#160;</font>8.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall be entitled to an aggregate of five (5) weeks vacation time annually during the Term, the time and duration thereof to be determined by mutual agreement between the Employee and the CEO.&#160; Any vacation
          time not used by the end of the Term shall be forfeited without compensation.&#160; In addition, the Employee shall not be entitled to carry over or use any vacation time that is unused as of the end of the Term.&#160; Further, the Employee shall be
          entitled to the number of sick, personal, family and other days off during the Term as set forth in KICO&#8217;s employee handbook.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><br>
        <font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">9.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;"> </font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>PARTICIPATION IN EMPLOYEE BENEFIT PLANS; RESTRICTED STOCK GRANTS</u></font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">9.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee shall be accorded the right to participate in and receive benefits under and in accordance with the
          provisions of any insurance, medical and dental insurance or reimbursement (with family coverage) or other plan or program of the Company or KICO (other than a pension or profit sharing plan or program), either in existence as of the Effective
          Date or thereafter adopted for the benefit generally of its executive employees<font style="font-family: 'Times New Roman',Times,serif;"><u>.</u></font>&#160; Additionally, in the event of termination of the Employee's employment by the
          Company without Cause, or by the Employee for Good Reason, the Company or KICO shall continue to provide to the Employee health, dental, and vision insurance coverage at no cost to the Employee (with family coverage) until (a) the end of the
          Severance Period (as hereinafter defined) or (b) such time as the Employee becomes eligible for similar coverage through a successor employer, whichever is sooner.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">9.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event the Company elects to discontinue any term life insurance policy purchased by it during the Term with respect
          to the Employee, prior to any such discontinuance and/or in the event the Employee&#8217;s employment with the Company ceases for any reason, the Employee shall be offered the opportunity to have such policy transferred to her without cost, it being
          understood that the Employee shall be responsible for the payment of any and all premiums thereafter due.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">9.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For each calendar year of the Term, the Employee will be eligible to participate in the Kingstone Companies, Inc. Amended
          and Restated 2014 Equity Participation Plan (the &#8220;Equity Plan&#8221;) on such basis as is determined in the discretion of the Board or an authorized committee thereof in accordance with the terms of the Equity Plan.&#160; Without limiting the generality of
          the foregoing, for each calendar year of the Term, subject to any contractual restrictions to which the Company may be bound, the Employee will be entitled to a grant on the first business day of such calendar year of a number of shares of Common
          Stock pursuant to Section 16 of the Equity Plan having a value equal to $136,500 divided by the fair market value of the Company&#8217;s Common Stock on the business day immediately preceding the date of grant, vesting as follows, based on continuous
          service with the Company as an employee, director or consultant through the applicable vesting date:</font></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z67a0868460cb4da78b463510ed7c9028" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 46.39%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif;">Grant for Calendar 2023</div>
          </td>
          <td style="width: 53.61%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">1/2 on first anniversary of grant date</div>
            <div style="font-size: 10pt; text-align: justify;">1/2 on December 31, 2024 <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 46.39%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">Grant for Calendar 2024</div>
          </td>
          <td style="width: 53.61%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">100% on December 31, 2024</div>
          </td>
        </tr>

    </table>
    <div>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Notwithstanding the foregoing, (a) the grants will vest earlier than the dates specified in the chart
        above to the extent provided for in the Equity Plan, (b) the Employee shall not be entitled to a grant of shares of Common Stock hereunder if, prior to the grant date, a Change of Control (as hereinafter defined) shall have occurred and (c) in the
        event the Employee is not entitled to receive a grant of shares of Common Stock pursuant to this Section 9.3 pursuant to the provisions hereof, including clause (b) above, then the Employee shall be entitled to receive in lieu of such grant a lump
        sum cash bonus in the amount of $136,500.</div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">10.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>SERVICE
            AS OFFICER AND DIRECTOR</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;10.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">During the Term, the Employee shall, if elected or appointed, serve as (a) an officer of the Company and/or any
          subsidiaries of the Company in existence or hereafter created or acquired and (b) a director of the Company and/or any such subsidiaries of the Company in existence or hereafter created or acquired, in each case without any additional
          compensation for such services. During the Term, the Company shall maintain in effect a directors and officers liability insurance policy of not less than $10 million in coverage limits, and the Company will include the Employee therein as a
          named insured.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">11.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>EARLIER
            TERMINATION</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee&#8217;s employment hereunder (a) shall automatically terminate upon her death, (b) may terminate at any time during
          the Term at the option of the Company upon written notice to the Employee for Cause or without Cause, (c) may terminate at any time during the Term at the option of the Employee upon written notice to the Company for Good Reason or without Good
          Reason and (d) may terminate at the option of the Company in the event the Employee becomes Disabled, as provided for in Article 6.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">As used in this Agreement, &#8220;Cause&#8221; shall mean (a) the Employee&#8217;s conviction by a court of competent jurisdiction of the
          commission of any act in the performance of her duties constituting common law fraud or a felony, (b) the Employee&#8217;s commission of any act involving moral turpitude which the Company&#8217;s Board of Directors reasonably believes may have a material
          adverse effect on the Company and its subsidiaries taken as a whole (&#8220;Material Adverse Effect&#8221;), (c) any misrepresentation by the Employee (including, without limitation, a breach of any representation set forth in Section 13.1 hereof) which the
          Company&#8217;s Board of Directors reasonably believes may have a Material Adverse Effect, (d) any breach of any material covenant on the Employee&#8217;s part herein set forth (which breach, if curable, is not cured by the Employee within thirty (30) days
          of the Employee&#8217;s receipt of written notice thereof from the Company), or (e) the Employee&#8217;s engagement in gross negligence or willful misconduct which the Company&#8217;s Board of Directors reasonably believes may have a Material Adverse Effect.&#160; The
          parties agree that the term &#8220;Material Adverse Effect&#8221; includes the loss or suspension of any license for the Company or KICO to operate or any disqualification or suspension for the Employee to serve as an officer or director thereof under
          applicable law.&#160; No act or failure to act by the Executive shall be considered &#8220;Cause&#8221; if the Executive&#8217;s act or failure to act was based on authority or express direction given by the CEO or the advice of counsel for the Company.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">As used in this Agreement, &#8220;Good Reason&#8221; shall mean (a) any breach of any material obligation on the Company&#8217;s part (which
          breach, if curable, is not cured by the Company within thirty (30) days of the Company&#8217;s receipt of written notice thereof from the Employee), (b) a material diminution in the Employee&#8217;s duties and responsibilities (other than following an event
          constituting Cause) in her capacity as Chief Operating Officer of the Company, (c) a change in the Employee's current reporting structure (other than following an event constituting Cause), or (d) a decrease in the compensation payable to the
          Employee from the compensation payable pursuant to this Agreement.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.4.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the termination of the Employee&#8217;s employment by the Company for Cause or by the Employee without Good
          Reason, the Company shall have no further obligations to the Employee, and the Employee shall be entitled to no further compensation from the Company, except (a) for any pro-rata amounts due to the Employee at such date of termination, as
          provided for in Section 4.2 hereof, and (b) in the case of a termination of employment by the Employee without Good Reason, for any Bonus amount for the completed calendar year immediately preceding the date of termination, as provided for in
          Section 4.3 hereof. As an illustration of the foregoing, in the event of a termination of employment by the Employee without Good Reason on March 1, the Employee would be entitled to receive the amount payable to her pursuant to Section 4.2
          hereof to March 1 and the amount, if any, payable to her pursuant to Section 4.3 hereof for the immediately preceding calendar year ended December 31.&#160; In the event of the termination of the Employee&#8217;s employment by the Company for Cause or by
          the Employee without Good Reason, the amount to be paid to the Employee pursuant to this Section 11.4 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any other or further compensation,
          rights or benefits hereunder or otherwise.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.5.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the termination of the Employee&#8217;s employment during the Term by the Company without Cause or by the
          Employee for Good Reason, as liquidated damages, the Employee shall be entitled to receive the compensation to which she would have been entitled pursuant to Section 4.2 until (a) the Expiration Date or (b) twelve (12) months from the Cessation
          Date, whichever is later (the &#8220;Severance Period&#8221;).&#160; The compensation payable pursuant to this Section 11.5 shall be payable to the Employee in accordance with the Company&#8217;s standard payroll practices as if her employment had continued.&#160; The
          amount to be paid to the Employee pursuant to this Section 11.5 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any other or further compensation, rights or benefits hereunder or otherwise
          other than as provided for in the stock grant agreements entered into as contemplated by Section 9.3.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.6.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In order to protect the Employee against the possible consequences and uncertainties of a Change of Control of the Company
          and thereby induce the Employee to remain in the employ of the Company, the Company agrees that:</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If, during the Term or thereafter, the Employee&#8217;s employment is terminated by the Company other than for Cause or by the
          Employee for Good Reason within eighteen (18) months subsequent to a Change of Control that occurs during the Term, the Company shall pay to the Employee an amount in cash equal to the sum of (i) one and one-half (1.5) times the Base Salary (as
          reduced pursuant to Section 4.2) and (ii) the Bonus through the Termination Date, calculated pursuant to Section 4.3(c) (the &#8220;Change of Control Payment&#8221;). The Change of Control Payment shall be payable in one lump sum payment within ten (10) days
          following the date of termination of employment, except that the Bonus through the Termination Date shall be payable as provided for in Section 4.3(d).&#160; In addition, in such event, the Company shall continue to pay for the Employee's health
          insurance premiums, including family coverage, until the later of (i) the Expiration Date or (ii) twelve (12) months from the Cessation Date.&#160; The Change of Control Payment shall be in lieu of the amount payable to the Employee pursuant to
          Section 11.5 hereof.&#160; The amount to be paid to the Employee pursuant to this Section 11.6 shall constitute the sole and exclusive remedy of the Employee, and the Employee shall not be entitled to any other or further compensation, rights or
          benefits hereunder or otherwise other than as provided for in any stock grant agreements entered into as contemplated by Section 9.3.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">As used in this Section 11.6, a &#8220;Change of Control&#8221; shall be deemed to have occurred if:</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">any &#8220;person&#8221; or &#8220;group of persons&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Securities&#160; Exchange Act of
          1934, as amended (the &#8220;1934 Act&#8221;) (other than the Employee or any &#8220;group of persons&#8221; that includes the Employee), becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 promulgated under the 1934 Act), directly or indirectly, of securities of
          the Company representing more than twenty-five percent (25%) of the Company&#8217;s then outstanding securities having the right to vote on the election of directors (&#8220;Voting Securities&#8221;), except that there shall be excluded from the calculation any
          Voting Securities acquired from the Company with respect to which the Employee gave her approval as a member of the Board;</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">when individuals who, as of the date hereof, constitute the Board (the &#8220;Incumbent Board&#8221;) cease for any reason to
          constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least a
          majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a
          result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the Company consummates (A) a reorganization, merger or consolidation of the Company, with respect to which in each case
          all or substantially all of the Persons who were the beneficial owners of the Voting Securities of the Company immediately prior to such reorganization, merger or consolidation do not, following such reorganization, merger or consolidation,
          beneficially own, directly and indirectly, more than 50% of the then combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of the corporation or other Person resulting from such
          reorganization, merger of consolidation, or (B) the sale or other disposition of all or substantially all of the assets of the Company.</font></div>
    </div>
    <div style="font-size: 10pt;">
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding the foregoing, no transaction or event shall constitute a Change of Control hereunder unless such transaction or event also
        constitutes a change in ownership or effective control of the Company within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(v) or (vi)(A)(2).</div>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.7.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event of the death of the Employee during the Term, as liquidated damages, the Employee&#8217;s estate (the &#8220;Estate&#8221;)
          shall be entitled to receive (a) the Base Salary to which the Employee is entitled until the date of death of the Employee pursuant to Section 4.2; and (b) the Bonus compensation to which the Employee is entitled through the date of death (i.e.,
          the Termination Date shall be considered the date of death).&#160; The amount to be paid to the Estate pursuant to this Section 11.7 shall constitute the sole and exclusive remedy of the Estate and any beneficiaries thereof, and neither the Estate nor
          any beneficiaries thereof shall be entitled to any other or further compensation, rights or benefits hereunder or otherwise, including pursuant to this Article 11 other than as provided for in any stock grant agreements entered into as
          contemplated by Section 9.3.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;11.8.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The termination or expiration of this Agreement shall not affect the continuing operation and effect of Article 7 hereof,
          which shall continue in full force and effect according to its terms.&#160; In addition, the termination or expiration of this Agreement will not result in a termination or waiver of any rights and remedies that the Company may have under this
          Agreement and applicable law.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">12.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>INJUNCTIVE
            RELIEF; REMEDIES</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;12.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee acknowledges and agrees that, in the event she shall violate or threaten to violate any of the restrictions
          of Article 3 or 7 hereof, the Company will be without an adequate remedy at law and will therefore be entitled to enforce such restrictions by temporary or permanent injunctive or mandatory relief in any court of competent jurisdiction without
          the necessity of proving monetary damages.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;12.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee agrees further that the Company shall have the following additional rights and remedies:</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the right and remedy to require the Employee to account for and pay over to the Company all monies and other consideration
          derived or received by her as the result of any transactions determined by an arbitrator or a court of competent jurisdiction to be a breach of any of the provisions of Section 7.1, and the Employee hereby agrees to account for and pay over such
          monies and other consideration to the Company; and</font></div>
      <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the right to recover attorneys&#8217; fees incurred in any action or proceeding in which it seeks to enforce its rights under
          Article 7 hereof and is successful on any grounds; provided, however, that, in the event the Employee is the prevailing party in any such action or proceeding, the Company will pay to the Employee all reasonable attorneys&#8217; fees and costs incurred
          by the Employee in defending such action or proceeding.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;12.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Each of the rights and remedies enumerated above shall be independent of the other, and shall be severally enforceable,
          and all of such rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or in equity.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">13.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>NO
            RESTRICTIONS</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: normal;">&#160;13.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee hereby represents that neither the execution of this Agreement nor her
          performance hereunder will (a) violate, conflict with or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under the terms, conditions or
          provisions of any contract, agreement or other instrument or obligation to which the Employee is a party, or by which she may be bound, or (b) violate any order, judgment, writ, injunction or decree applicable to the Employee.&#160; In the event of a
          breach hereof, in addition to the Company&#8217;s right to terminate this Agreement, the Employee shall indemnify the Company and hold it harmless from and against any and all claims, losses, liabilities, costs and expenses (including reasonable
          attorneys&#8217; fees) incurred or suffered in connection with or as a result of the Company&#8217;s entering into this Agreement or employing the Employee hereunder.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">14.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>ARBITRATION</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;14.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Except with regard to Section 12.1 hereof and any other matters that are not a proper subject of arbitration, all disputes
          between the parties hereto concerning the performance, breach, construction or interpretation of this Agreement or any portion thereof, or in any manner arising out of this Agreement or the performance thereof, shall be submitted to binding
          arbitration, in accordance with the rules of the American Arbitration Association.&#160; The arbitration proceeding shall take place at a mutually agreeable location in Nassau County, New York or such other location as agreed to by the parties.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;14.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The award rendered by the arbitrator shall be final, binding and conclusive, shall be specifically enforceable, and
          judgment may be entered upon it in accordance with applicable law in an appropriate court in the State of New York, with no right of appeal therefrom.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;14.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Each party shall pay its or her own expenses of arbitration, and the expenses of the arbitrator and the arbitration
          proceeding shall be borne by the Company; provided, however, that, if, in the opinion of the arbitrator (or a majority of the arbitrators if more than one), any claim or defense was unreasonable, the arbitrator(s) may assess, as part of their
          award, all or any part of the arbitration expenses of the other party (including reasonable attorneys&#8217; fees) and of the arbitrator(s) and the arbitration proceeding against the party raising such unreasonable claim or defense; provided, further,
          that, if the arbitration proceeding relates to the issue of Cause for termination of employment, (a) if, in the opinion of the arbitrator (or a majority of the arbitrators if more than one), Cause existed, the arbitrator(s) shall assess, as part
          of their award, all of the arbitration expenses of the Company (including reasonable attorneys&#8217; fees) and of the arbitrator(s) and the arbitration proceeding against the Employee or (b) if, in the opinion of the arbitrator (or a majority of the
          arbitrators if more than one), Cause did not exist, the arbitrator(s) shall assess, as part of their award, all of the arbitration expenses of the Employee (including reasonable attorneys&#8217; fees) and of the arbitrator(s) and the arbitration
          proceeding (as provided for hereinabove) against the Company.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font>15.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>CODE
              SECTIONS 409A, 280G AND 4999</u></font>.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;15.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The intent of the parties is that payments and benefits under this Agreement comply with Section 409A of the Code
          (together with the regulations and guidance promulgated thereunder, &#8220;Code Section 409A&#8221;), and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith.&#160; To the extent that any provision
          hereof is modified in order to comply with Code Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to the parties hereto of the
          applicable provision without violating the provisions of Code Section 409A.&#160; In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on the Employee by Code Section 409A as a result of
          the Company&#8217;s compliance with the terms of this Agreement.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;15.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing
          for the payment of any amounts or benefits&#160;constituting deferred compensation under Code Section 409A upon or following a termination of employment unless such termination of employment is also a &#8220;separation from service&#8221; within the meaning of
          Code Section 409A and, for purposes of any such provision of this Agreement, references to a termination of employment or like terms shall mean &#8220;separation from service.&#8221;&#160; If the Employee is deemed on the date of termination to be a &#8220;specified
          employee&#8221; within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provision of any benefit that is considered deferred compensation under Code Section 409A payable on account of a &#8220;separation from
          service,&#8221; such payment or benefit shall be made or provided at the date which is the earlier of (i) the expiration of the six (6) month period measured from the date of such &#8220;separation from service&#8221; of the Employee, and (ii) the date of the
          Employee&#8217;s death (the &#8220;Delay Period&#8221;).&#160; Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section&#160;15.2 (whether they would have otherwise been payable in a single sum or in installments in the absence of
          such delay) shall be paid or reimbursed to the Employee in a lump sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified herein.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;15.3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">All expenses or other reimbursements under this Agreement shall be made on or prior to the last day of the taxable year
          following the taxable year in which such expenses were incurred by the Employee (provided that if any such reimbursements constitute taxable income to the Employee, such reimbursements shall be paid no later than March 15th of the calendar year
          following the calendar year in which the expenses to be reimbursed were incurred), and no such reimbursement or expenses eligible for reimbursement in any taxable year shall in any way affect the expenses eligible for reimbursement in any other
          taxable year.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;15.4.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes of Code Section 409A, the Employee&#8217;s right to receive any installment payments pursuant to this Agreement
          shall be treated as a right to receive a series of separate and distinct payments.&#160; Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., &#8220;payment shall be made within&#160;sixty (60) days&#8221;), the
          actual date of payment within the specified period shall be within the sole discretion of the Company.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;15.5.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In no event shall any payment under this Agreement that constitutes &#8220;deferred compensation&#8221; for purposes of Code Section
          409A be offset by any other payment pursuant to this Agreement or otherwise.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;15.6.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding any other provisions of this Agreement to the contrary, in the event that any payments or benefits
          received or to be received by the Employee in connection with the Employee&#8217;s employment with the Company (or termination thereof) would subject the Employee to the excise tax imposed under Section 280G or 4999 of the Code (the &#8220;Excise Tax&#8221;), and,
          if the net-after tax amount (taking into account all applicable taxes payable by the Employee, including any Excise Tax) that the Employee would receive with respect to such payments or benefits does not exceed the net-after tax amount the
          Employee would receive if the amount of such payment and benefits were reduced to the maximum amount which could otherwise be payable to the Employee without the imposition of the Excise Tax, then, to the extent necessary to eliminate the
          imposition of the Excise Tax, (i) such cash payments and benefits shall first be reduced (if necessary, to zero) and (ii) all other non-cash payments and benefits shall next be reduced. The determination of whether any reduction in such payments
          or benefits to be provided under this Agreement or otherwise is required pursuant to the preceding sentence will be made at the expense of the Company by independent accountants or benefits consultants selected by the Company, and the Employee
          shall have the right to review such determination.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font>16.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u>ASSIGNMENT</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;16.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">This Agreement, as it relates to the employment of the Employee, is a personal contract and the rights and interests of
          the Employee hereunder may not be sold, transferred, assigned, pledged or hypothecated.</font></div>
      <div style="font-size: 10pt;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">17.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>NOTICES</u></font></div>
      <div style="font-size: 10pt;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;17.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Any notice required or permitted to be given pursuant to this Agreement shall be deemed to have been duly given when
          delivered by hand or sent by certified or registered mail, return receipt requested and postage prepaid, overnight mail or courier, e-mail, or fax as follows:</font></div>
    </div>
    <div style="font-size: 10pt;">
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif;">If to the Employee:</div>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">2 Buritts Landing North</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Westport, Connecticut 06880</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">merylsgolden@gmail.com</div>
    </div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">with a copy to:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Madsen Prestley &amp; Parenteau</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">402 Asylum Street</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Hartford, Connecticut 06103</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Attention: Peter Prestley, Esq.</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Pbprestley@mppjustice.com</u></div>
    </div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">If to the Company:</div>
    </div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">c/o William Yankus</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Chairman, Compensation Committee</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">10 Pheasant Hill Road</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Farmington, Connecticut 06032</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>wyankus@comcast.net</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">with a copy to:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Certilman Balin Adler &amp; Hyman, LLP</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">90 Merrick Avenue</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">East Meadow, New York 11554</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Attention:&#160; Fred Skolnik, Esq.</div>
      <div style="text-align: justify; margin-left: 72pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">fskolnik@certilmanbalin.com</div>
    </div>
    <div>
      <div style="text-align: justify; margin-left: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Fax Number: (516) 296-7111</div>
      <div style="font-size: 10pt;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;</font></div>
    </div>
    <div>
      <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">or at such other address as any party shall designate by notice to the other party given in accordance with this Section
        17.1.</div>
      <div style="font-size: 10pt;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">18.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>GOVERNING
            LAW</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;18.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of New York
          applicable to agreements made and to be performed entirely in New York without regard to conflicts of laws principles.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">19.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>WAIVER OF
            BREACH; PARTIAL INVALIDITY</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;19.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The waiver by either party of a breach of any provision of this Agreement shall not operate or be construed as a waiver of
          any subsequent breach.&#160; If any provision, or part thereof, of this Agreement shall be held to be invalid or unenforceable, such invalidity or unenforceability shall attach only to such provision and not in any way affect or render invalid or
          unenforceable any other provisions of this Agreement, and this Agreement shall be carried out as if such invalid or unenforceable provision, or part thereof, had been reformed, and any court of competent jurisdiction or arbitrators, as the case
          may be, are authorized to so reform such invalid or unenforceable provision, or part thereof, so that it would be valid, legal and enforceable to the fullest extent permitted by applicable law.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">20.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>ENTIRE
            AGREEMENT; AMENDMENT</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;20.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and there
          are no representations, warranties or commitments except as set forth herein.&#160; This Agreement supersedes all prior agreements, understandings, negotiations and discussions, whether written or oral, of the parties hereto relating to the subject
          matter hereof.&#160; This Agreement may be amended, and any provision hereof waived, only by a writing executed by the party sought to be charged.&#160; No amendment or waiver on the part of the Company shall be valid unless approved by its Board.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">21.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>COUNTERPARTS</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">21.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which
          taken together shall constitute one and the same instrument.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">22.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>FACSIMILE
            AND EMAIL SIGNATURES</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;22.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Signatures hereon which are transmitted via facsimile or email shall be deemed original signatures.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">23.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>EXPENSES</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;23.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Company agreed to pay the reasonable fees and expenses of legal counsel incurred by the Employee in connection with
          the drafting and negotiation of the Employment Agreement; provided, however, that the amount payable pursuant to this Section 23.1 shall not exceed $5,000.</font></div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;23.2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In addition to the right to indemnification conferred in Article Thirteenth of the Restated Certificate of Incorporation
          of the Company, as amended (the &#8220;Certificate of Incorporation&#8221;), and Article VII, Section 7 of the By-Laws of the Company, as amended (the &#8220;By-Laws&#8221;), the Employee shall have the right to have her expenses (including reasonable attorneys&#8217; fees)
          incurred in defending any action or proceeding as to which the Employee is entitled to be indemnified in advance of its final disposition advanced and paid promptly as set forth below upon incurring such expenses; provided, however, that an
          advancement of expenses incurred by the Employee shall be made only upon delivery to the Company of an undertaking by the Employee to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there
          is no further right to appeal that the Employee is not entitled to be indemnified for such expenses under the Certificate of Incorporation or the By-Laws.&#160; The Company shall make advance payments of such expenses (including reasonable attorneys'
          fees) incurred within thirty (30) days of the Employee&#8217;s presentation of an invoice for such expenses.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">24.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>CONSTRUCTION</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: normal;">&#160;24.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">All references in this Agreement to &#8220;includes&#8221; and &#8220;including&#8221; shall be construed
          to include the words &#8220;without limitation.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">25.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>REPRESENTATION
            BY COUNSEL; INTERPRETATION</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;25.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Employee acknowledges that she has been represented by counsel in connection with this Agreement. Accordingly, any
          rule of law or any legal decision that would require the interpretation of any claimed ambiguities in this Agreement against the party that drafted it has no application and is expressly waived by the Employee.&#160; The provisions of this Agreement
          shall be interpreted in a reasonable manner to give effect to the intent of the parties hereto.</font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160; </font><font style="font-weight: normal;">26.</font></font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt; font-weight: normal;">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>HEADINGS</u></font></div>
    </div>
    <div>
      <div style="margin-bottom: 12pt; text-indent: 72pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;26.1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The headings and captions under articles and sections of this Agreement are for convenience of reference only and do not
          in any way modify, interpret or construe the intent of the parties or affect any of the provisions of this Agreement.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">[Remainder of page intentionally left blank.&#160; Signature page follows.]</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the day and year above written.</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; margin-left: 252pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">KINGSTONE COMPANIES, INC.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 252pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">By:</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 180pt;"> /s/</font></div>
      <div style="text-align: justify; margin-left: 252pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Barry B. Goldstein</div>
      <div style="text-align: justify; margin-left: 252pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;Chief Executive Officer</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 252pt;"><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 180pt;">&#160;/s/</font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: justify; margin-left: 252pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Meryl S. Golden</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Approved:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify;"><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 144pt;">&#160;/s/</font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">William Yankus</div>
      <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Chair, Compensation Committee</div>
    </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>ex10_3.htm
<DESCRIPTION>AMENDED AND RESTATED 2014 EQUITY PARTICIPATION PLAN
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">
      <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal;">Adopted on June 23, 2022</div>
      <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
        </font> </div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">KINGSTONE COMPANIES, INC.</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">AMENDED AND RESTATED</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">2014 EQUITY PARTICIPATION PLAN</div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Kingstone Companies, Inc. (the &#8220;Company&#8221;) originally adopted the Kingstone Companies, Inc. 2014 Equity Participation Plan (the
      &#8220;Original Plan&#8221;) effective as of August 12, 2014 and hereby amends and restates the Original Plan in the form of this Kingstone Companies, Inc. Amended and Restated 2014 Equity Participation Plan (the &#8220;Plan&#8221;) effective as of May 27, 2020, the date on
      which the Plan is approved by the Company&#8217;s Board of Directors.</div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">1.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Purpose</u></font>.&#160; The Plan is intended to advance
        the interests of the Company by inducing individuals or entities of outstanding ability and potential to join and remain with, or provide consulting or advisory services to, the Company or a parent or subsidiary of the Company, by encouraging and
        enabling eligible employees, non-employee directors, consultants and advisors to acquire proprietary interests in the Company, and by providing the participating employees, non-employee directors, consultants and advisors with an additional
        incentive to promote the success of the Company.&#160; This is accomplished by providing for the granting of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, and Stock Bonuses, as such terms are defined in Section 2
        hereof, to employees, non-employee directors, consultants and advisors.&#160; <font style="font-family: 'Times New Roman',Times,serif;">As used herein, the term &#8220;parent&#8221; or &#8220;subsidiary&#8221; shall mean any present or future entity which is or
          would be a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; of the Company as the term is defined in Section&#160;424 of the Code (as hereinafter defined) (determined as if the Company were the employer corporation).</font></font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">2.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Definitions</u></font>.&#160; <font style="font-family: 'Times New Roman',Times,serif;">Capitalized terms not otherwise defined in the Plan shall have the following meanings:</font></font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Award Agreement&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>shall mean a written agreement,
        as amended, in such form as the Committee shall determine, that evidences the terms and conditions of a Stock Award granted under the Plan<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">.</font></font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Board&#8221; shall mean the Board of Directors of the Company.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Code&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>shall mean the Internal Revenue Code of 1986, as amended.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#8220;Committee&#8221; shall mean a committee or subcommittee of the Board to whom
          authority has been granted by the Board to make determinations with regard to the Plan, </font>which committee or subcommittee shall consist of at least two persons, each of whom is intended to be an &#8220;outside independent director&#8221; to the extent
        required by the rules and regulations of any established stock exchange or a national market system, including, without limitation, The Nasdaq Stock Market (&#8220;Nasdaq&#8221;).</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Common Stock&#8221; shall mean the common stock, $.01 par value, of the Company.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(f)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of 1934, as amended.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(g)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;&#8220;Fair Market Value&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>on a specified date means the value of a share of
        Common Stock, determined as follows:</font></div>
    <div style="margin-bottom: 12pt; text-indent: 144pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 35.55pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">if the Common Stock is listed on any established stock exchange or a national market system, including, without limitation, Nasdaq, its Fair
        Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or system on the day immediately preceding the day of determination (or, if the determination is made after the
        close of business for trading, then on the day of determination) as reported in The Wall Street Journal or such other source as the Committee deems reliable;</font></div>
    <div style="margin-bottom: 12pt; text-indent: 144pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">if the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair Market Value shall be the
        mean between the high bid and low asked prices for the Common Stock on the day immediately preceding the day of determination (or, if the determination is made after the close of business for trading, then on the day of determination), as reported
        in The Wall Street Journal or such other source as the Committee deems reliable;&#160;or</font></div>
    <div style="margin-bottom: 12pt; text-indent: 144pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">in the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good faith by the Committee under a
        method that complies with Code Sections 422 and 409A, if applicable.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(h)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;&#8220;Incentive Stock Option&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>shall mean an Option that
        is an &#8220;incentive stock option&#8221; within the meaning of Section&#160;422 of the Code and that is identified as an Incentive Stock Option in the Award Agreement by which it is evidenced.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Nonstatutory Stock Option&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>shall mean an Option
        that is not an Incentive Stock Option within the meaning of Section&#160;422 of the Code.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(j)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Option&#8221; shall mean an Incentive Stock Option or a Nonstatutory Stock Option.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(k)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;&#8220;Section 409A of the Code&#8221; means the nonqualified deferred compensation rules under Section 409A of the Code and any applicable Treasury
        regulations thereunder.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(l)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Securities Act&#8221; shall mean the Securities Act of 1933, as amended.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(m)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Stock Appreciation Right&#8221; or &#8220;SAR&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>shall mean a
        right to receive payment of the appreciated value of shares of Common Stock as provided for in Section 10 hereof.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(n)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Stock Award&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>shall mean an Incentive Stock Option,
        a Nonstatutory Stock Option, a Stock Appreciation Right or a Stock Bonus award.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(o)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;Stock Bonus&#8221;<font style="font-family: 'Times New Roman',Times,serif; font-style: italic;">&#160;</font>shall mean a bonus award payable in
        shares of Common Stock as provided for in Section&#160;16 hereof.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">3.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Administration</u></font>.&#160; The Plan shall be
        administered by the Board or the Committee.&#160; All references in the Plan to the &#8220;Committee&#8221; shall be deemed to refer to the &#8220;Board&#8221; if no committee is established for the purpose of making determinations with respect to the Plan.&#160; Except as herein
        specifically provided, the interpretation and construction by the Committee of any provision of the Plan or of any Stock Award granted under it shall be final and conclusive.&#160; The Committee may, in its sole discretion, adopt special guidelines and
        provisions for persons who are residing in or employed in, or subject to the taxes of, any domestic or foreign jurisdictions to comply with applicable tax and securities laws of such domestic or foreign jurisdictions.&#160; The receipt of a Stock Award
        by any members of the Committee shall not preclude their vote on any matters in connection with the administration or interpretation of the Plan.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">4.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Shares Subject to the Plan</u></font>.&#160; The shares
        subject to Stock Awards granted under the Plan shall be the Common Stock, whether authorized but unissued or held in the Company&#8217;s treasury, or shares purchased from stockholders expressly for use under the Plan.&#160; The maximum number of shares of
        Common Stock which may be issued pursuant to Stock Awards granted under the Plan shall not exceed in the aggregate one million four hundred thousand (1,400,000) shares.&#160; The Company shall at all times while the Plan is in force reserve such number
        of shares of Common Stock as will be sufficient to satisfy the requirements of all outstanding Stock Awards granted under the Plan. In the event any Option or SAR granted under the Plan shall expire or terminate for any reason without having been
        exercised in full or shall cease for any reason to be exercisable in whole or in part, the unpurchased shares subject thereto shall again be available for Stock Awards under the Plan.&#160; In the event the right to receive any Stock Bonus is terminated
        for any reason, the shares forfeited shall again be available for Stock Awards under the Plan. In the event shares of Common Stock are delivered to, or withheld by, the Company pursuant to Section 13(b) or 31 hereof, such delivered or withheld
        shares shall be considered to have been issued pursuant to the Plan and shall not be available for Stock Awards under the Plan.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">5.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Participation</u></font>.&#160; The class of individuals and
        entities that shall be eligible to receive Stock Awards (&#8220;Grantees&#8221;) under the Plan shall be (a) with respect to Incentive Stock Options, all employees of either the Company or any parent or subsidiary of the Company, and (b) with respect to all
        other Stock Awards, all employees and non-employee directors of, and consultants and advisors to, either the Company or any parent or subsidiary of the Company; provided, however, no Stock Award shall be granted to any such consultant or advisor
        unless (i) the consultant or advisor is a natural person (or an entity wholly-owned, directly or indirectly, by a natural person), (ii) <font style="font-family: 'Times New Roman',Times,serif;"><u>bona</u></font>&#160;<font style="font-family: 'Times New Roman',Times,serif;"><u>fide</u></font> services have been or are to be rendered by such consultant or advisor and (iii) such services are not in connection with the offer or sale of securities in a
        capital raising transaction and do not directly or indirectly promote or maintain a market for the Company&#8217;s securities.&#160; The Committee, in its sole discretion, but subject to the provisions of the Plan, shall determine the employees and
        non-employee directors of, and the consultants and advisors to, the Company and its parents and subsidiaries to whom Stock Awards shall be granted, and the number of shares to be covered by each Stock Award grant, taking into account the nature of
        the employment or services rendered by the individuals or entities being considered, their annual compensation, their present and potential contributions to the success of the Company, and such other factors as the Committee may deem relevant.&#160; For
        purposes hereof, a non-employee to whom an offer of employment has been extended shall be considered an employee, provided that the Stock Award granted to such individual shall not be exercisable or vest, in whole or in part, for a period of at
        least one year from the date of grant and, in the event the individual does not commence employment with the Company, the Stock Award granted shall be considered null and void.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">6.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Award Agreement</u></font>.&#160; Each Stock Award granted
        under the Plan shall be authorized by the Committee and shall be evidenced by an Award Agreement which shall be executed by the Company and, in the discretion of the Committee, by the individual or entity to whom such Stock Award is granted.&#160; The
        Award Agreement shall specify the number of shares of Common Stock as to which the Stock Award is granted, the period during which any Option or SAR is exercisable and the option or base price per share thereof, the vesting periods for any Stock
        Bonus, any performance-based vesting criteria (the &#8220;Performance Goals&#8221;) and such other terms and provisions as the Committee may deem necessary or appropriate; provided, however, that, no more than one-third of any Stock Award may vest before the
        first anniversary of the date of grant of such Stock Award.&#160; The terms of an Award Agreement, including the option or base price per share for an Option or SAR, may be amended from time to time upon the mutual written agreement of the Company (as
        authorized by the Committee) and the Grantee; provided, however, that an Award Agreement may not be amended to accelerate the vesting period(s) of a Stock Award (except in the event of the death or termination of employment of a Grantee due to
        Permanent Disability (as hereinafter defined)).</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">7.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Incentive Stock Options</u></font>.&#160; The Committee may
        grant Incentive Stock Options under the Plan which are subject to the following terms and conditions and any other terms and conditions as may at any time be required by Section 422 of the Code:</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No Incentive Stock Option shall be granted to individuals other than employees of the Company or of a parent or subsidiary of the Company.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Each Incentive Stock Option under the Plan must be granted prior to August 12, 2024, which is within ten years from the date the Original Plan was
        adopted by the Board.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The option price of the shares subject to any Incentive Stock Option shall not be less than the Fair Market Value of the Common Stock at the time
        such Incentive Stock Option is granted; provided, however, if an Incentive Stock Option is granted to an individual who owns, at the time the Incentive Stock Option is granted, more than 10% of the total combined voting power of all classes of
        stock of the Company or of a parent or subsidiary of the Company (a &#8220;10% Stockholder&#8221;), the option price of the shares subject to the Incentive Stock Option shall be at least 110% of the Fair Market Value of the Common Stock at the time such
        Incentive Stock Option is granted.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No Incentive Stock Option granted under the Plan shall be exercisable after the expiration of ten years from the date of its grant; provided,
        however, if an Incentive Stock Option is granted to a 10% Stockholder, such Incentive Stock Option shall not be exercisable after the expiration of five years from the date of its grant.&#160; Every Incentive Stock Option granted under the Plan shall be
        subject to earlier termination as expressly provided in Section 12 hereof.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes of determining stock ownership under this Section 7, the attribution rules of Section 424(d) of the Code shall apply.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">8.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Nonstatutory Stock Options</u></font>.&#160; The Committee
        may grant Nonstatutory Stock Options under the Plan.&#160; Nonstatutory Stock Options shall be subject to the following terms and conditions:</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">A Nonstatutory Stock Option may be granted to any individual or entity eligible to receive an Option under the Plan pursuant to clause (b) of
        Section 5 hereof.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The option price of the shares subject to a Nonstatutory Stock Option shall not be less than the Fair Market Value of the Common Stock at the time
        such Nonstatutory Stock Option is granted.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No Nonstatutory Stock Option granted under the Plan shall be exercisable after the expiration of ten years from the date of its grant.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">9.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">[<font style="font-family: 'Times New Roman',Times,serif;"><u>Intentionally Omitted</u></font>]</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">10.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Stock Appreciation Rights</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Committee may grant Stock Appreciation Rights to such persons eligible under the Plan as the Committee may select from time to time.&#160; SARs
        shall be granted at such times, in such amounts and under such other terms and conditions as the Committee shall determine, which terms and conditions shall be evidenced under an Award Agreement, subject to the terms of the Plan. Subject to the
        terms and conditions of the Award Agreement, an SAR shall entitle the Grantee to exercise the SAR, in whole or in part, in exchange for a payment of shares of Common Stock, cash or a combination thereof, as determined by the Committee and provided
        for in the Award Agreement, equal in value to the excess of the Fair Market Value of the shares of Common Stock underlying the SAR, determined on the date of exercise, over the base amount set forth in the Award Agreement for the shares of Common
        Stock underlying the SAR, which base amount shall not be less than the Fair Market Value of such Common Stock, determined as of the date the SAR is granted.&#160; The Company may, in its sole discretion, withhold from any such cash payment any amount
        necessary to satisfy the Company&#8217;s obligation for withholding taxes with respect to such payment.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No SAR granted under the Plan shall be exercisable after the expiration of ten years from the date of its grant.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">All references in the Plan to &#8220;Options&#8221; shall be deemed to include &#8220;SARs&#8221; where applicable.</font></div>

    <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">11.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;"> </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Transferability</u></font>.</font></div>
    </div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No Option granted under the Plan shall be transferable by the individual or entity to whom it was granted other than by will or the laws of
        descent and distribution, and, during the lifetime of an individual, shall not be exercisable by any other person, but only by him.&#160; Rights with respect to Stock Bonuses may not be sold, assigned, transferred, pledged, hypothecated or otherwise
        disposed of except by will or the laws of descent and distribution (subject to the provisions of the Plan).</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding Section 11(a) above, a Nonstatutory Stock Option granted under the Plan may be transferred in whole or in part during a Grantee&#8217;s
        lifetime, upon the approval of the Committee, to a Grantee&#8217;s &#8220;family members&#8221; (as such term is defined in Rule 701(c)(3) of the Securities Act and General Instruction A(1)(a)(5) to Form S-8) through a gift or domestic relations order.&#160; The
        transferred portion of a Nonstatutory Stock Option may only be exercised by the person or entity who acquires a proprietary interest in such Option pursuant to the transfer.&#160; The terms applicable to the transferred portion shall be the same as
        those in effect for the Option immediately prior to such transfer and shall be set forth in such documents issued to the transferee as the Committee may deem appropriate.&#160; As used in the Plan, the terms &#8220;Grantee&#8221; (when referring to an Option
        recipient) and &#8220;holder of an Option&#8221; shall refer to the grantee of the Option and not any transferee thereof.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">12.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Effect of Termination of Employment or Death on Options</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Unless otherwise provided in the Award Agreement and except as provided in subsections (b) and (c) of this Section 12 and Section 19 hereof, if
        the employment of an employee by, or the services of a non-employee director for, or consultant or advisor to, the Company or a parent or subsidiary of the Company, shall terminate for any reason, then his Option may be exercised at any time within
        three months after such termination, subject to the provisions of subsection (d) of this Sections 12.&#160; For purposes of this subsection (a), an employee, non-employee director, consultant or advisor who leaves the employ or services of the Company
        to become an employee or non-employee director of, or a consultant or advisor to, a parent or subsidiary of the Company or a corporation (or subsidiary or parent of the corporation) which has assumed the Option of the Company as a result of a
        corporate reorganization or like event shall not be considered to have terminated his employment or services.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Unless otherwise provided in the Award Agreement, if the holder of an Option under the Plan dies (i) while employed by, or while serving as a
        non-employee director for or a consultant or advisor to, the Company or a parent or subsidiary of the Company, or (ii) within three months after the termination of his employment or services for any reason, then such Option may, subject to the
        provisions of subsection (d) of this Section 12, be exercised by the estate of the employee or non-employee director, consultant or advisor, or by a person who acquired the right to exercise such Option by bequest or inheritance or by reason of the
        death of such employee or non-employee director, consultant or advisor, at any time within one year after such death.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Unless otherwise provided in the Award Agreement, if the holder of an Option under the Plan ceases employment or services because of permanent and
        total disability (within the meaning of Section 23(e)(3) of the Code) (&#8220;Permanent Disability&#8221;) while employed by, or while serving as a non-employee director for or consultant or advisor to, the Company or a parent or subsidiary of the Company,
        then such Option may, subject to the provisions of subsection (d) of this Section 12, be exercised at any time within one year after his termination of employment, termination of directorship or termination of consulting or advisory services, as
        the case may be, due to the disability.&#160; Notwithstanding the foregoing, in the event the Company is a party to an employment, consulting or advisory agreement with a Grantee and such agreement provides for termination of employment or engagement
        based upon a disability or other incapacity, then, for such Grantee, a termination of employment or engagement for disability or other incapacity pursuant to the provisions thereof shall be considered to be a termination based upon Permanent
        Disability for purposes hereof.&#160; Furthermore, notwithstanding the foregoing, with respect to Stock Awards that are subject to Section 409A of the Code, Permanent Disability shall mean that a Grantee is disabled under Section 409A(a)(2)(c)(i) or
        (ii) of the Code.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Subject to Sections 6 and 19 hereof and this Section 12, an Option may not be exercised pursuant to this Section 12 except to the extent that the
        holder was entitled to exercise the Option at the time of termination of employment, termination of directorship, termination of consulting or advisory services, or death, and in any event may not be exercised after the expiration of the Option.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes of this Section 12, the employment relationship of an employee of the Company or of a parent or subsidiary of the Company will be
        treated as continuing intact while he is on military or sick leave or other bona fide leave of absence (such as temporary employment by the Government) if such leave does not exceed 90 days, or, if longer, so long as his right to reemployment is
        guaranteed either by statute or by contract.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">13.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Exercise of Options</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Unless otherwise provided in the Award Agreement, any Option granted under the Plan shall be exercisable, subject to vesting, in whole at any
        time, or in part from time to time, prior to expiration.&#160; The Committee, in its absolute discretion, may provide in any Award Agreement that the exercise of any Options granted under the Plan shall be subject (i) to such condition or conditions as
        it may impose, including, but not limited to, a condition that the holder thereof remain in the employ or service of, or continue to provide consulting or advisory services to, the Company or a parent or subsidiary of the Company for such period or
        periods from the date of grant of the Option as the Committee, in its absolute discretion, shall determine; and (ii) to such limitations as it may impose, including, but not limited to, a limitation that the aggregate Fair Market Value (determined
        at the time the Option is granted) of the Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any employee during any calendar year (under all plans of the Company and its parents and subsidiaries) shall
        not exceed $100,000.&#160; In addition, in the event that under any Award Agreement the aggregate Fair Market Value (determined at the time the Option is granted) of the Common Stock with respect to which Incentive Stock Options are exercisable for the
        first time by any employee during any calendar year (under all plans of the Company and its parents and subsidiaries corporations) exceeds $100,000, the Committee may, when shares are transferred upon exercise of such Options, designate those
        shares which shall be treated as transferred upon exercise of an Incentive Stock Option and those shares which shall be treated as transferred upon exercise of a Nonstatutory Stock Option.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">An Option granted under the Plan shall be exercised by the delivery by the holder thereof to the Company at its principal office (attention of the
        Secretary) of written notice of the number of shares with respect to which the Option is being exercised.&#160; Such notice shall be accompanied, or followed within ten days of delivery thereof, by payment of the full option price of such shares, and
        payment of such option price shall be made by the holder&#8217;s delivery of (i) his check payable to the order of the Company, or (ii) previously acquired Common Stock, the Fair Market Value of which shall be determined as of the date of exercise
        (provided that the shares delivered pursuant hereto are acceptable to the Committee in its sole discretion) or (iii) if provided for in the Award Agreement, and subject to the provisions of applicable law, his check payable to the order of the
        Company in an amount at least equal to the par value of the Common Stock being acquired, together with a promissory note, in form and upon such terms as are acceptable to the Committee, made payable to the order of the Company in an amount equal to
        the balance of the exercise price, or (iv) by the holder&#8217;s delivery of any combination of the foregoing (i), (ii) and (iii).&#160; Alternatively, if provided for in the Award Agreement, the holder may elect to have the Company reduce the number of
        shares otherwise issuable by a number of shares having a Fair Market Value equal to the exercise price of the Option being exercised.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">14.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Further Conditions of Exercise of Options</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Unless prior to the exercise of the Option the shares issuable upon such exercise have been registered with the Securities and Exchange Commission
        pursuant to the Securities Act, the notice of exercise shall be accompanied by a representation or agreement of the person or estate exercising the Option to the Company to the effect that such shares are being acquired for investment purposes and
        not with a view to the distribution thereof, and such other documentation as may be required by the Company, unless in the opinion of counsel to the Company such representation, agreement or documentation is not necessary to comply with the
        Securities Act.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If the Common Stock is listed on any securities exchange, including, without limitation, Nasdaq, the Company shall not be obligated to deliver any
        Common Stock pursuant to this Plan until it has been listed on each such exchange. In addition, the Company shall not be obligated to deliver any Common Stock pursuant to this Plan until there has been qualification under or compliance with such
        federal or state laws, rules or regulations as the Company may deem applicable.&#160; The Company shall use reasonable efforts to obtain such listing, qualification and compliance.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">15.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">[<font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Intentionally Omitted</u></font>]</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">16.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Stock Bonus Grants</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Committee may grant Stock Bonus awards to such persons eligible under the Plan as the Committee may select from time to time.&#160; Stock Bonus
        awards shall be granted at such times, in such amounts and under such other terms and conditions as the Committee shall determine, which terms and conditions shall be evidenced under an Award Agreement, subject to the terms of the Plan.&#160; Upon
        satisfaction of any conditions, limitations and restrictions set forth in the Award Agreement, a Stock Bonus award shall entitle the recipient to receive payment of a bonus described under the Stock Bonus award in the form of shares of Common
        Stock.&#160; Prior to the date on which a Stock Bonus award is required to be paid under an Award Agreement, the Stock Bonus award shall constitute an unfunded, unsecured promise by the Company to distribute Common Stock in the future.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Committee may condition the grant or vesting of Stock Bonus Awards upon the attainment of specified Performance Goals set forth on Exhibit A
        as the Committee may determine, in its sole discretion.&#160; Such Performance Goals may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and
        acquisitions) and other similar type events or circumstances.&#160; The applicable Performance Goals shall be based on one or more of the performance criteria set forth in Exhibit A hereto.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Shares granted pursuant to a Stock Bonus shall vest as determined by the Committee, as provided for in the Award Agreement.&#160; The foregoing
        notwithstanding (but subject to the discretion of the Committee and Section 19 hereof and except as otherwise provided in the Award Agreement), a Grantee shall forfeit the right to receive all shares not previously vested, if any, at such time as
        the Grantee is no longer employed by, or serving as a director of, or rendering consulting or advisory services to, the Company or a parent or subsidiary of the Company for any reason.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">17.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Adjustment Upon Change in Capitalization</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">In the event that the outstanding Common Stock is hereafter changed by reason of reorganization, merger, consolidation, recapitalization,
        reclassification, stock split-up, combination of shares, reverse split, stock dividend or the like, an appropriate adjustment shall be made by the Committee in (i) the aggregate number of shares available under the Plan, (ii) the number of shares
        and option price per share subject to outstanding Options, (iii) the number of shares issuable pursuant to outstanding Stock Bonus grants, and (iv) any limitation on exercisability referred to in Section 13(a)(ii) hereof which is set forth in
        outstanding Incentive Stock Options.&#160; If the Company shall be reorganized, consolidated, or merged with another corporation, subject to the provisions of Section 22 hereof, the holder of an Option shall be entitled to receive upon the exercise of
        his Option, and the Grantee of a Stock Bonus shall be entitled to receive upon satisfaction of any conditions, limitations and restrictions set forth in the Award Agreement with respect to the Stock Bonus, the same number and kind of shares of
        stock or the same amount of property, cash or securities as he would have been entitled to receive upon the happening of any such corporate event as if he had been, immediately prior to such event, the holder of the number of shares covered by his
        Option or subject to the Stock Bonus; provided, however, that, in such event, the Committee shall have the discretionary power to take any action necessary or appropriate to prevent any Incentive Stock Option granted hereunder which is intended to
        be an &#8220;incentive stock option&#8221; from being disqualified as such under the then existing provisions of the Code or any law amendatory thereof or supplemental thereto; and provided, further, that in such event the Committee shall have the
        discretionary power to take any action necessary or appropriate to prevent such adjustment from being deemed or considered as the adoption of a new plan requiring shareholder approval under Section 422 of the Code and the regulations promulgated
        thereunder.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Any adjustment in the number of shares shall apply proportionately to only the unexercised portion of the Option, or the unissued shares subject
        to an outstanding Stock Bonus, granted hereunder.&#160; If fractions of a share would result from any such adjustment, the adjustment shall be revised to the next lower whole number of shares.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">18.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Rights of Grantees</u></font>.&#160; The holder of an Option
        granted under the Plan shall have none of the rights of a stockholder with respect to the Common Stock covered by his Option until such Common Stock shall be transferred to him upon the exercise of his Option.&#160; The recipient of a Stock Bonus under
        the Plan shall have none of the rights of a stockholder with respect to the Common Stock covered by the Stock Bonus until the date on which the Grantee is entitled to receive the Common Stock pursuant to the Award Agreement.</font></div>
    <div style="text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">19.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Special Provisions as to Vesting</u></font>.</font></div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding anything hereinabove to the contrary, in the event a Grantee is not an employee or non-employee director of, or a consultant or
        advisor to, the Company as of a particular vesting date for a Stock Award due to death or termination of employment, termination of directorship, or termination of consulting or advisory services due to Permanent Disability, then, for purposes of
        the Plan and the Stock Award, the Grantee shall be deemed to have remained an employee or non-employee director of, or a consultant or advisor to, the Company through the vesting date next following the Grantee&#8217;s death or termination of employment,
        termination of directorship, or termination of consulting or advisory services due to Permanent Disability.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding anything to the contrary, in the event a Change of Control (as hereinafter defined) occurs, then, immediately prior to the Change
        of Control, all outstanding Stock Awards granted pursuant to Section 16 hereof shall become fully vested.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, a &#8220;Change of Control&#8221; shall be deemed to have occurred if:</font></div>
    <div style="text-indent: 139.5pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 40.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">any &#8220;person&#8221; or &#8220;group of persons&#8221; (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act) (other than the Grantee or any &#8220;group of persons&#8221; that
        includes the Grantee), becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Company representing more than thirty-three and one-third percent (33-1/3%) of the
        Company&#8217;s then outstanding securities having the right to vote on the election of directors (&#8220;Voting Securities&#8221;), except that there shall be excluded from the calculation any Voting Securities acquired from the Company with respect to which the
        Grantee, if a director, gave his approval as a member of the Board;</font></div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="text-indent: 139.5pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 40.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;individuals who, as of the date on which the Plan is adopted by the Board, constitute the Board (the &#8220;Incumbent Board&#8221;) cease for any reason to constitute at least a
        majority of the Board; provided, however, that any individual becoming a director subsequent to such date whose election, or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least a majority of the directors then
        comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened
        election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board; or</font></div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="text-indent: 144pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the Company consummates (A) a reorganization, merger or consolidation of the Company, with respect to which in each case all or substantially all of the persons who were
        the beneficial owners of the Voting Securities of the Company immediately prior to such reorganization, merger or consolidation do not, following such reorganization, merger or consolidation, beneficially own, directly and indirectly, more than 50%
        of the then combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of the corporation or other person resulting from such reorganization, merger of consolidation, or (B) the sale or
        other disposition of all or substantially all of the assets of the Company.</font></div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">For purposes hereof, &#8220;Cause&#8221; shall mean (i) the Grantee&#8217;s conviction by a court of competent jurisdiction of the commission of any act in the
        performance of the Grantee&#8217;s duties constituting common law fraud or a felony, (ii) the Grantee&#8217;s commission of any act involving moral turpitude which the Board reasonably believes may have a material adverse effect on the Company and its
        subsidiaries taken as a whole (&#8220;Material Adverse Effect&#8221;), or (iii) the Grantee&#8217;s engagement in gross negligence or willful misconduct which the Board&#160; reasonably believes will have a Material Adverse Effect.&#160; The term &#8220;Material Adverse Effect&#8221;
        includes the loss or suspension of any license for the Company to operate or any disqualification or suspension for the Grantee to serve as an officer or director of the Company under applicable law.&#160; No act or failure to act by the Grantee shall
        be considered &#8220;Cause&#8221; if the Grantee&#8217;s act or failure to act was based on authority or express direction given by the Chief Executive Officer of the Company or the advice of counsel for the Company.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding the provisions of Section 12 hereof, in the event a Grantee is deemed to have remained an employee or non-employee director of, or
        a consultant or advisor to, the Company through the vesting date next following the Grantee&#8217;s death or termination of employment, termination of directorship, or termination of consulting or advisory services due to Permanent Disability, as
        provided for above, then, with respect to any Option that is subject thereto, such Option, with respect to such next vesting, shall remain exercisable until the later of (A) three months following such next vesting date or (B) one year following
        the date of death or date of termination of employment, termination of directorship, or termination of consulting or advisory services due to Permanent Disability, as the case may be, subject to the provisions of paragraph (d) of Section 12 hereof.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">20.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Restrictions Upon Shares; Right of First Refusal</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No Grantee shall, for value or otherwise, sell, assign, transfer or otherwise dispose of all or any part of the shares issued pursuant to the
        exercise of an Option or pursuant to a Stock Bonus (collectively, the &#8220;Shares&#8221;), or of any beneficial interest therein (collectively a &#8220;Disposition&#8221;), except as permitted by and in accordance with the provisions of the Plan.&#160; The Company shall not
        recognize as valid or give effect to any Disposition of any Shares or interest therein upon the books of the Company unless and until the Grantee desiring to make such Disposition shall have complied with the provisions of the Plan.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No Grantee shall, without the written consent of the Company, pledge, encumber, create a security interest in or lien on, or in any way attempt to
        otherwise impose or suffer to exist any lien, attachment, levy, execution or encumbrance on the Shares.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If, at any time, a Grantee desires to make a Disposition of any of the Shares (the &#8220;Offered Shares&#8221;) to any third-party individual or entity
        pursuant to a bona fide offer (the &#8220;Offer&#8221;), he shall give written notice of his intention to do so (&#8220;Notice of Intent to Sell&#8221;) to the Company, which notice shall specify the name(s) of the offeror(s) (the &#8220;Proposed Offeror(s)&#8221;), the price per
        share offered for the Offered Shares and all other terms and conditions of the proposed transaction.&#160; Thereupon, the Company shall have the option to purchase from the Grantee all, but not less than all, the Offered Shares upon the same terms and
        conditions as set forth in the Offer.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If the Company desires to purchase all of the Offered Shares, it must send a written notice to such effect to the Grantee within 30 days following
        receipt of the Notice of Intent to Sell.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The closing of any purchase and sale of the Offered Shares shall take place 60 days following receipt by the Company of the Notice of Intent to
        Sell.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(f)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If the Company does not elect to purchase all of the Offered Shares within the period set forth in paragraph (d) hereof, no Shares may be
        purchased by the Company, and the Grantee shall thereupon be free to dispose of such Shares to the Proposed Offeror(s) strictly in accordance with the terms of the Offer.&#160; If the Offered Shares are not disposed of strictly in accordance with the
        terms of the Offer within a period of 120 days after the Grantee gives a Notice of Intent to Sell, such Shares may not thereafter be sold without compliance with the provisions hereof.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(g)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">All certificates representing the Shares shall bear on the face or reverse side thereof the following legend:</font></div>
    <div style="text-align: justify; margin-right: 108pt; margin-left: 108pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#8220;The shares represented by this certificate are subject to the provisions of the
      Kingstone Companies, Inc. Amended and Restated 2014 Equity Participation Plan, a copy of which is on file at the offices of the Company.&#8221;</div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(h)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The provisions of this Section 20 shall only take effect if expressly provided for in the particular Award Agreement, shall be of no force or
        effect during such time that the Company is subject to the reporting requirements of the Exchange Act pursuant to Section 13 or 15(d) thereof and shall be subject to the provisions of any and all agreements hereafter entered into to which both the
        Company and any Grantee are parties that provide for a right of first refusal with respect to the Disposition of Shares.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">21.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Transactions Requiring Stockholder Approval</u></font>.
        Each of the following shall require approval by the affirmative vote of the holders of a majority of the votes of the shares of Common Stock present in person or represented by proxy at a meeting of stockholders and entitled to vote thereon (or in
        the case of action by written consent in lieu of a meeting of stockholders, the number of votes required by applicable law to act in lieu of a meeting) (&#8220;Stockholder Approval&#8221;):</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the amendment of an outstanding Option to reduce the exercise price thereof;</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the cancellation of an outstanding Option in exchange for either the grant of an Option that has an exercise price that is less than the exercise
        price of the cancelled Option or the grant of another Stock Award;</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the cancellation of an Option whose exercise price is greater than the then Fair Market Value of the Common Stock (&#8220;Underwater Option&#8221;) in
        exchange for a Stock Award;</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">a cash buyout of an Underwater Option; and</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(e)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">the transfer of an Option to a third-party financial intuition.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">22.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Liquidation, Merger or Consolidation</u></font>.
        Notwithstanding Section 13(a) hereof, if the Board approves a plan of complete liquidation or a merger or consolidation (other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior
        thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity), at least 50% of the combined voting power of the voting securities of the Company (or such surviving entity)
        outstanding immediately after such merger or consolidation), the Committee may, in its sole discretion, upon written notice to the holder of an Option, provide that the Option must be exercised within 20 days following the date of such notice or it
        will be terminated.&#160; In the event such notice is given, the Option shall become immediately exercisable in full.&#160; With regard to a merger or consolidation, any such Option exercise shall take effect immediately prior to the closing of such
        transaction.&#160; In the event such merger or consolidation is not consummated within six (6) months of the date of the notice given to the holder of the Option, such notice and any such exercise shall be deemed null and void.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">23.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#8220;<font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Market Stand&#8209;off&#8221;</u></font>.&#160; No Grantee may, without
        the prior written consent of the managing underwriter, do any of the following during the period commencing on the date of the final prospectus relating to any underwritten public offering of the Company&#8217;s Common Stock under the Securities Act (the
        &#8220;Public Offering&#8221;) and ending on the date specified by the Company and the managing underwriter (such period not to exceed 180 days; provided, however, that, if (a) during the last 17 days of the initial lock-up period, the Company releases
        earnings results or announces material news or a material event or (b) prior to the expiration of the initial lock-up period, the Company announces that it will release earnings results during the 15-day period following the last day of the initial
        lock-up period, then in each case the lock-up period will be automatically extended until the expiration of the 18-day period beginning on the date of release of the earnings results or the announcement of the material news or material event, as
        applicable): (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or
        indirectly, any of the Shares held immediately before the effective date of the registration statement for such offering or (ii)&#160;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
        consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise.&#160; The foregoing provisions of this Section 23
        shall be applicable to the Grantees only if all officers, directors, and stockholders individually owning more than 5% of the Company&#8217;s outstanding Common Stock are subject to the same restrictions.&#160; The underwriters in connection with such
        registration are intended third&#8209;party beneficiaries of this Section 23 and shall have the right, power, and authority to enforce the provisions hereof as though they were a party to the Award Agreement executed pursuant hereto.&#160; Each Grantee shall
        execute such agreements as may be reasonably requested by the Company in connection with such registration that are consistent with this Section 23 or that are necessary to give further effect thereto.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">24.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Effectiveness of the Plan</u></font>.&#160; The Original Plan
        was adopted by the Board on August 12, 2014 (the &#8220;Adoption Date&#8221;), and by the stockholders of the Company on August 11, 2015. The Plan was adopted in this amended and restated form by the Board on June __, 2022.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">25.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Termination, Modification and Amendment</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Plan (but not Options previously granted under the Original Plan or the Plan) shall terminate on August 12, 2024 (the &#8220;Termination Date&#8221;),
        which is within ten years from the Adoption Date, or sooner as hereinafter provided, and no Stock Award shall be granted after termination of the Plan.&#160; The foregoing shall not be deemed to limit the vesting period for Options, SARs, or Stock
        Bonuses granted pursuant to the Plan.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Plan may from time to time be terminated, modified, or amended if Stockholder Approval of the termination, modification or amendment is
        obtained.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding paragraph (b) hereof, the Board may at any time, on or before the Termination Date, without Stockholder Approval, terminate the
        Plan, or from time to time make such modifications or amendments to the Plan as it may deem advisable; provided, however, that the Board shall not, without Stockholder Approval, (i) increase (except as otherwise provided by Section 17 hereof) the
        maximum number of shares as to which Incentive Stock Options may be granted hereunder, change the designation of the employees or class of employees eligible to receive Incentive Stock Options, or make any other change which would prevent any
        Incentive Stock Option granted hereunder which is intended to be an &#8220;incentive stock option&#8221; from qualifying as such under the then existing provisions of the Code or any law amendatory thereof or supplemental thereto or (ii) make any other
        modifications or amendments that require Stockholder Approval pursuant to applicable law, regulation or exchange requirements.&#160; In the event Stockholder Approval is not received within one year of adoption by the Board of the change provided for in
        (i) or (ii) above, then, unless otherwise provided in the Award Agreement (but subject to applicable law), the change and all Stock Awards that may have been granted pursuant thereto shall be null and void.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">No termination, modification, or amendment of the Plan may, without the consent of the Grantee to whom any Stock Award shall have been granted,
        adversely affect the rights conferred by such Stock Award.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">26.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Not a Contract of Employment</u></font>.&#160; Nothing
        contained in the Plan or in any Award Agreement executed pursuant hereto shall be deemed to confer upon any individual or entity to whom a Stock Award is or may be granted hereunder any right to remain in the employ or service of the Company or a
        parent or subsidiary of the Company or any entitlement to any remuneration or other benefit pursuant to any consulting or advisory arrangement.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">27.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Use of Proceeds</u></font>.&#160; The proceeds from the sale
        of shares pursuant to Stock Awards granted under the Plan shall constitute general funds of the Company.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">28.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Indemnification of Board of Directors or Committee</u></font>.&#160;
        In addition to such other rights of indemnification as they may have, the members of the Board or the Committee, as the case may be, shall be indemnified by the Company to the extent permitted under applicable law against all costs and expenses
        reasonably incurred by them in connection with any action, suit, or proceeding to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan or any rights granted thereunder and
        against all amounts paid by them in settlement thereof or paid by them in satisfaction of a judgment of any such action, suit or proceeding, except a judgment based upon a finding of bad faith.&#160; Upon the institution of any such action, suit, or
        proceeding, the member or members of the Board or the Committee, as the case may be, shall notify the Company in writing, giving the Company an opportunity at its own cost to defend the same before such member or members undertake to defend the
        same on his or their own behalf.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">29.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Captions</u></font>.&#160; The use of captions in the Plan
        is for convenience.&#160; The captions are not intended to provide substantive rights.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">30.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Disqualifying Dispositions</u></font>.&#160; If Common Stock
        acquired upon exercise of an Incentive Stock Option granted under the Plan is disposed of within two years following the date of grant of the Incentive Stock Option or one year following the issuance of the Common Stock to the Grantee, or is
        otherwise disposed of in a manner that results in the Grantee being required to recognize ordinary income, rather than capital gain, from the disposition (a &#8220;Disqualifying Disposition&#8221;), the holder of the Common Stock shall, immediately prior to
        such Disqualifying Disposition, notify the Company in writing of the date and terms of such Disqualifying Disposition and provide such other information regarding the Disqualifying Disposition as the Company may reasonably require.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.3pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">31.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.7pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Withholding Taxes</u></font>.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Whenever under the Plan shares of Common Stock or cash are to be delivered to a Grantee upon exercise of a Nonstatutory Stock Option or to a
        Grantee of a Stock Bonus, the Company shall be entitled to require as a condition of delivery that the Grantee remit or, at the discretion of the Committee, agree to remit when due, an amount sufficient to satisfy all current or estimated future
        Federal, state and local income tax withholding requirements, including, without limitation, the employee&#8217;s portion of any employment tax requirements relating thereto.&#160; At the time of a Disqualifying Disposition, the Grantee shall remit to the
        Company in cash the amount of any applicable Federal, state and local income tax withholding and the employee&#8217;s portion of any employment taxes.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The Committee may, in its discretion, provide any or all holders of Nonstatutory Stock Options or Grantees of Stock Bonus with the right to use
        shares of Common Stock in satisfaction of all or part of the withholding taxes to which such holders may become subject in connection with the exercise of their Options or their receipt of a Stock Bonus.&#160; Such right may be provided to any such
        holder in either or both of the following formats:</font></div>
    <div style="margin-bottom: 12pt; text-indent: 144pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 35.55pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The election to have the Company withhold, from the shares of Common Stock otherwise issuable upon the exercise of such Nonstatutory Stock Option
        or the satisfaction of the conditions, limitations and restrictions with respect to a Stock Bonus, a portion of those shares with an aggregate fair market value equal to the percentage of the withholding taxes (not to exceed 100%) designated by the
        holder.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 144pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 35.55pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">The election to deliver to the Company, at the time the Nonstatutory Stock Option is exercised or the conditions, limitations and restrictions
        are satisfied for a Stock Bonus, one or more shares of Common Stock previously acquired by such holder (other than in connection with the Option exercise or Stock Bonus grant triggering the withholding taxes) with an aggregate Fair Market Value
        equal to the percentage of the withholding taxes (not to exceed 100%) designated by the holder.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Notwithstanding the foregoing, the Committee may, in its discretion, permit the use of shares of Common Stock, as provided for in paragraph (b)
        hereof, to satisfy income tax liabilities of the Grantee in excess of withholding tax requirements provided that such additional income tax liabilities are reasonably likely to be incurred by the Grantee.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">32.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Excise Tax</u></font>. In the event any Stock Award
        hereunder shall become subject to the excise tax imposed under Section 4999 of the Code, or any similar or successor provision of federal, state or local law, the Grantee shall not be paid any amounts to offset the tax effect of such excise tax or
        taxes.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">33.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Section 409A of the Code</u></font>.&#160; Although the
        Company does not guarantee the particular tax treatment of Stock Awards granted under the Plan, Stock Awards made under the Plan are intended to comply with, or be exempt from, the applicable requirements of Section 409A of the Code and the Plan
        and any Award Agreement hereunder shall be limited, construed and interpreted in accordance with such intent.&#160; To the extent that any Stock Award is subject to Section 409A of the Code, it shall be paid in a manner that will comply with Section
        409A of the Code, including proposed, temporary or final regulations or any other guidance issued by the Secretary of the Treasury and the Internal Revenue Service with respect thereto.&#160; In no event whatsoever shall the Company or any of its
        affiliates be liable for any additional tax, interest or penalties that may be imposed on a Grantee by Section 409A of the Code or any damages for failing to comply with Section 409A of the Code or this Section 33. Notwithstanding anything in the
        Plan or in a Stock Award to the contrary, the following provisions shall apply to any Stock Award granted under the Plan that constitutes "non-qualified deferred compensation" pursuant to Section 409A of the Code (a &#8220;409A Covered Award&#8221;):</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">A termination of employment shall not be deemed to have occurred for purposes of any provision of a 409A Covered Award providing for payment upon
        or following a termination of the Grantee&#8217;s employment unless such termination is also a "Separation from Service" within the meaning of Code Section 409A and, for purposes of any such provision of a 409A Covered Award, references to a
        &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean Separation from Service. Notwithstanding any provision to the contrary in the Plan or the Stock Award, if the Grantee is deemed on the date of the Grantee&#8217;s termination of service
        to be a &#8220;specified employee&#8221; within the meaning of that term under Code Section 409A(a)(2)(B) and using the identification methodology selected by the Company from time to time, or if none, the default methodology set forth in Code Section 409A,
        then with regard to any such payment under a 409A Covered Award, to the extent required to be delayed in compliance with Code Section 409A(a)(2)(B), such payment shall not be made prior to the earlier of (i) the expiration of the six (6)-month
        period measured from the date of the Grantee&#8217;s Separation from Service, and (ii) the date of the Grantee&#8217;s death.&#160; All payments delayed pursuant to this Section 33 shall be paid to the Grantee on the first day of the seventh month following the
        date of the Grantee&#8217;s Separation from Service or, if earlier, on the date of the Grantee&#8217;s death.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Whenever a payment under a 409A Covered Award specifies a payment period with reference to a number of days, the actual date of payment within the
        specified period shall be within the sole discretion of the Company.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 108pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(c)</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 34.5pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">If under a 409A Covered Award an amount is to be paid in two or more installments, for purposes of Code Section 409A, each installment shall be
        treated as a separate payment.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">34.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Other Provisions</u></font>.&#160; Each Stock Award under
        the Plan may contain such other terms and conditions not inconsistent with the Plan as may be determined by the Committee, in its sole discretion.&#160; Notwithstanding the foregoing, each Incentive Stock Option granted under the Plan shall include
        those terms and conditions which are necessary to qualify the Incentive Stock Option as an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code and the regulations thereunder and shall not include any terms and conditions which
        are inconsistent therewith.</font></div>
    <div style="margin-bottom: 12pt; text-indent: 71.25pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">35.</font><font style="display: inline-block; text-indent: 0px; font-size: 10pt; width: 36.75pt;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Governing Law</u></font>.&#160; The Plan shall be governed
        by, and all questions arising hereunder shall be determined in accordance with, the laws of the State of Delaware, excluding choice of law principles thereof.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Exhibit A</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">PERFORMANCE GOALS</div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Performance Goals for the purposes of the vesting of performance-based Stock Awards shall be based upon one or more of the
      following business criteria (which may be determined for these purposes by reference to (i) the Company as a whole, (ii) any of the Company&#8217;s subsidiaries, operating divisions, regional business units or other operating units, or (iii) any
      combination thereof): profit before taxes, stock price, market share, gross revenue, net revenue, pre-tax income, operating income, cash flow, earnings per share, return on equity, return on invested capital or assets, cost reductions and savings,
      return on revenues or productivity, or any other business criteria the Committee deems appropriate, which may be modified at the discretion of the Committee to take into account significant nonrecurring items, or an event or events either not
      directly relating to the operations of the Company or not within the reasonable control of the Company&#8217;s management, or a change in accounting standards required by generally accepted accounting principles, or which may be adjusted to reflect such
      costs or expenses as the Committee deems appropriate.</div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140597243073360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 23, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 23,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KINGSTONE COMPANIES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-01665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-2476480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 Joys Lane<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kingston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">802-7900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000033992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KINS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="kins-20220623.xsd" xlink:type="simple"/>
    <context id="c20220623to20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000033992</identifier>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220623to20220623"
      id="Fact_ea5f61622aab41bc9d751ddb6405e31d">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220623to20220623"
      id="Fact_ffabec57efd1456ea346d958bc7c4f74">0000033992</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20220623to20220623"
      id="Fact_80335468e4574b79a6a0466af4db3d82">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20220623to20220623"
      id="Fact_db48f16b68b54d42a1f03887607d11af">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220623to20220623"
      id="Fact_999c62f185aa49b68d574ec8e5089f89">2022-06-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220623to20220623"
      id="Fact_5b90b89a57b1436d952ef7054c38fbe1">KINGSTONE COMPANIES, INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber
      contextRef="c20220623to20220623"
      id="Fact_26bae341cdca4a438c9b02a9ed54a28f">000-01665</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220623to20220623"
      id="Fact_b6b2559e76b241ada7a646a239e328a4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220623to20220623"
      id="Fact_f86e65dd5034486db320f46109a273a9">36-2476480</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220623to20220623"
      id="Fact_4bd4d2dbf4b049449409a5b757e5bdfb">15 Joys Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220623to20220623"
      id="Fact_ba4f8b66f6384fffbfc90426fc66a2b2">Kingston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220623to20220623"
      id="Fact_b0d0d337706e44d29931a6b9926acee1">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220623to20220623"
      id="Fact_a0d547783d454b4088cb2bdc7adf4238">12401</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220623to20220623"
      id="Fact_11ae8a074ab44becbcdec3ffae34397c">845</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220623to20220623"
      id="Fact_250f1bd0646a418abc280f17faf84045">802-7900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220623to20220623"
      id="Fact_bd3e91b0773043b19432f73b7a2142dd">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220623to20220623"
      id="Fact_0f48012ea73f4187bab9216eba6f2965">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220623to20220623"
      id="Fact_c33f4e11402c41f8969ed03cce205f80">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220623to20220623"
      id="Fact_b48f5e5166d040618bb2d6099785213e">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220623to20220623"
      id="Fact_123de43c2b62480d81686a6782dfefdb">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220623to20220623"
      id="Fact_a099d0e9bc554633affed62cd2e4be35">KINS</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220623to20220623"
      id="Fact_d81a3762e185404a93465e5d6403756a">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MR!";W37'-!_BF\[KQT='KR1Z&ZE>])HQ0][21.B^LS8FNW%=':U92O6%S)B
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .N#W%0D'INBK0   /@!   :
M          "  <@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( .N#W%1ED'F2&0$  ,\#   3              "  :T2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /<3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kingstonecompanies.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8k.htm">form8k.htm</File>
    <File>kins-20220623.xsd</File>
    <File>kins-20220623_lab.xml</File>
    <File>kins-20220623_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "kins-20220623_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kins-20220623_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "kins-20220623.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "kins",
   "nsuri": "http://kingstonecompanies.com/20220623",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20220623to20220623",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://kingstonecompanies.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20220623to20220623",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://kingstonecompanies.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001021771-22-000033-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001021771-22-000033-xbrl.zip
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M+4^87KH8<>INP!RR/H>EY^/$X[P?7?63'R9)_"6ZTG(!PB?Y'!7(3=PHG&[
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MU!6]9ZQXJ!==L@^3F]_Q*XBO02/QJVD: ZPXNB48-K<C#.4(AHL8RH*(1?M
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M2SMR%V&I5+?\A/@J^MXB/L17MS_]!U!+ 0(4 Q0    ( .N#W%0/%1<'\!<
M &Q]   *              "  0    !F;W)M.&LN:'1M4$L! A0#%     @
MZX/<5'>HP@Q9 P  D0\  !$              ( !&!@  &MI;G,M,C R,C V
M,C,N>'-D4$L! A0#%     @ ZX/<5/.$* 6!"   <E@  !4
M ( !H!L  &MI;G,M,C R,C V,C-?;&%B+GAM;%!+ 0(4 Q0    ( .N#W%3.
M;G(W[ 4   ,_   5              "  50D  !K:6YS+3(P,C(P-C(S7W!R
;92YX;6Q02P4&      0 ! #]    <RH

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
